<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">38865966</PMID><DateCompleted><Year>2024</Year><Month>06</Month><Day>12</Day></DateCompleted><DateRevised><Year>2024</Year><Month>06</Month><Day>29</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1097-4180</ISSN><JournalIssue CitedMedium="Internet"><Volume>57</Volume><Issue>6</Issue><PubDate><Year>2024</Year><Month>Jun</Month><Day>11</Day></PubDate></JournalIssue><Title>Immunity</Title><ISOAbbreviation>Immunity</ISOAbbreviation></Journal><ArticleTitle>Challenges and opportunities in long COVID research.</ArticleTitle><Pagination><StartPage>1195</StartPage><EndPage>1214</EndPage><MedlinePgn>1195-1214</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.immuni.2024.05.010</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S1074-7613(24)00264-4</ELocationID><Abstract><AbstractText>Long COVID (LC) is a condition in which patients do not fully recover from the initial SARS-CoV-2 infection but rather have persistent or new symptoms for months to years following the infection. Ongoing research efforts are investigating the pathophysiologic mechanisms of LC and exploring preventative and therapeutic treatment approaches for patients. As a burgeoning area of investigation, LC research can be structured to be more inclusive, innovative, and effective. In this perspective, we highlight opportunities for patient engagement and diverse research expertise, as well as the challenges of developing definitions and reproducible studies. Our intention is to provide a foundation for collaboration and progress in understanding the biomarkers and mechanisms driving LC.</AbstractText><CopyrightInformation>Copyright &#xa9; 2024 Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Hamlin</LastName><ForeName>Rebecca E</ForeName><Initials>RE</Initials><AffiliationInfo><Affiliation>Department of Medicine, Stanford University, Stanford, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Blish</LastName><ForeName>Catherine A</ForeName><Initials>CA</Initials><AffiliationInfo><Affiliation>Department of Medicine, Stanford University, Stanford, CA, USA; Chan Zuckerberg Biohub, San Francisco, CA, USA. Electronic address: cblish@stanford.edu.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>OT2 HL161847</GrantID><Acronym>HL</Acronym><Agency>NHLBI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>T32 AI007502</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Immunity</MedlineTA><NlmUniqueID>9432918</NlmUniqueID><ISSNLinking>1074-7613</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015415">Biomarkers</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015415" MajorTopicYN="N">Biomarkers</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D035843" MajorTopicYN="N">Biomedical Research</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="Y">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="Y">SARS-CoV-2</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">PASC</Keyword><Keyword MajorTopicYN="N">long COVID</Keyword><Keyword MajorTopicYN="N">long-haul COVID</Keyword><Keyword MajorTopicYN="N">post-COVID conditions</Keyword><Keyword MajorTopicYN="N">post-acute sequelae of SARS-CoV-2 infection</Keyword></KeywordList><CoiStatement>Declaration of interests C.A.B. is a scientific advisory board member of ImmuneBridge, DeepCell, Inc., and Qihan Bio on topics unrelated to this manuscript.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>1</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>4</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>5</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2025</Year><Month>6</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>6</Month><Day>13</Day><Hour>0</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>6</Month><Day>13</Day><Hour>0</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>6</Month><Day>12</Day><Hour>18</Hour><Minute>16</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38865966</ArticleId><ArticleId IdType="mid">NIHMS1996460</ArticleId><ArticleId IdType="pmc">PMC11210969</ArticleId><ArticleId IdType="doi">10.1016/j.immuni.2024.05.010</ArticleId><ArticleId IdType="pii">S1074-7613(24)00264-4</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Zhu N, Zhang D, Wang W, Li X, Yang B, Song J, Zhao X, Huang B, Shi W, Lu R, et al. (2020). A Novel Coronavirus from Patients with Pneumonia in China, 2019. N. Engl. J. Med 382, 727&#x2013;733. 10.1056/NEJMoa2001017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2001017</ArticleId><ArticleId IdType="pmc">PMC7092803</ArticleId><ArticleId IdType="pubmed">31978945</ArticleId></ArticleIdList></Reference><Reference><Citation>WHO Coronavirus (COVID-19) Dashboard.   https://covid19.who.int.</Citation></Reference><Reference><Citation>Chaudhary N, Weissman D, and Whitehead KA (2021). mRNA vaccines for infectious diseases: principles, delivery and clinical translation. Nat. Rev. Drug Discov 20, 817&#x2013;838. 10.1038/S41573-021-00283-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/S41573-021-00283-5</ArticleId><ArticleId IdType="pmc">PMC8386155</ArticleId><ArticleId IdType="pubmed">34433919</ArticleId></ArticleIdList></Reference><Reference><Citation>Decades in the Making: mRNA COVID-19 Vaccines NIH COVID-19 Res. https://covid19.nih.gov/nih-strategic-response-covid-19/decades-making-mrna-covid-19-vaccines.</Citation></Reference><Reference><Citation>Ball P (2020). The lightning-fast quest for COVID vaccines &#x2014; and what it means for other diseases. Nature 589, 16&#x2013;18. 10.1038/d41586-020-03626-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/d41586-020-03626-1</ArticleId><ArticleId IdType="pubmed">33340018</ArticleId></ArticleIdList></Reference><Reference><Citation>Altmann DM, Whettlock EM, Liu S, Arachchillage DJ, and Boyton RJ (2023). The immunology of long COVID. Nat. Rev. Immunol 23, 618&#x2013;634. 10.1038/s41577-023-00904-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41577-023-00904-7</ArticleId><ArticleId IdType="pubmed">37433988</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen B, Julg B, Mohandas S, Bradfute SB, and RECOVER Mechanistic Pathways Task Force (2023). Viral persistence, reactivation, and mechanisms of long COVID. eLife 12, e86015. 10.7554/eLife.86015.</Citation><ArticleIdList><ArticleId IdType="doi">10.7554/eLife.86015</ArticleId><ArticleId IdType="pmc">PMC10159620</ArticleId><ArticleId IdType="pubmed">37140960</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis HE, McCorkell L, Vogel JM, and Topol EJ (2023). Long COVID: major findings, mechanisms and recommendations. Nat. Rev. Microbiol 21, 133&#x2013;146. 10.1038/s41579-022-00846-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41579-022-00846-2</ArticleId><ArticleId IdType="pmc">PMC9839201</ArticleId><ArticleId IdType="pubmed">36639608</ArticleId></ArticleIdList></Reference><Reference><Citation>Desimmie BA, Raru YY, Awadh HM, He P, Teka S, and Willenburg KS (2021). Insights into SARS-CoV-2 Persistence and Its Relevance. Viruses 13, 1025.10.3390/v13061025.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v13061025</ArticleId><ArticleId IdType="pmc">PMC8228265</ArticleId><ArticleId IdType="pubmed">34072390</ArticleId></ArticleIdList></Reference><Reference><Citation>Nalbandian A, Sehgal K, Gupta A, Madhavan MV, McGroder C, Stevens JS, Cook JR, Nordvig AS, Shalev D, Sehrawat TS, et al. (2021). Post-acute COVID-19 syndrome. Nat. Med 27, 601&#x2013;615. 10.1038/s41591-021-01283-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01283-z</ArticleId><ArticleId IdType="pmc">PMC8893149</ArticleId><ArticleId IdType="pubmed">33753937</ArticleId></ArticleIdList></Reference><Reference><Citation>Peluso MJ, and Deeks SG (2022). Early clues regarding the pathogenesis of long-COVID. Trends Immunol. 43, 268&#x2013;270. 10.1016/j.it.2022.02.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.it.2022.02.008</ArticleId><ArticleId IdType="pmc">PMC8901423</ArticleId><ArticleId IdType="pubmed">35272932</ArticleId></ArticleIdList></Reference><Reference><Citation>Proal AD, and VanElzakker MB (2021). Long COVID or Post-acute Sequelae of COVID-19 (PASC): An Overview of Biological Factors That May Contribute to Persistent Symptoms. Front. Microbiol 12, 698169. 10.3389/fmicb.2021.698169.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmicb.2021.698169</ArticleId><ArticleId IdType="pmc">PMC8260991</ArticleId><ArticleId IdType="pubmed">34248921</ArticleId></ArticleIdList></Reference><Reference><Citation>Proal AD, VanElzakker MB, Aleman S, Bach K, Boribong BP, Buggert M, Cherry S, Chertow DS, Davies HE, Dupont CL, et al. (2023). SARS-CoV-2 reservoir in postacute sequelae of COVID-19 (PASC). Nat. Immunol, 1&#x2013;12. 10.1038/s41590-023-01601-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41590-023-01601-2</ArticleId><ArticleId IdType="pubmed">37667052</ArticleId></ArticleIdList></Reference><Reference><Citation>Ramakrishnan RK, Kashour T, Hamid Q, Halwani R, and Tleyjeh IM (2021). Unraveling the Mystery Surrounding Post-Acute Sequelae of COVID-19. Front. Immunol 12, 686029. 10.3389/fimmu.2021.686029.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.686029</ArticleId><ArticleId IdType="pmc">PMC8278217</ArticleId><ArticleId IdType="pubmed">34276671</ArticleId></ArticleIdList></Reference><Reference><Citation>Sherif ZA, Gomez CR, Connors TJ, Henrich TJ, Reeves WB, and RECOVER Mechanistic Pathway Task Force (2023). Pathogenic mechanisms of post-acute sequelae of SARS-CoV-2 infection (PASC). eLife 12, e86002. 10.7554/eLife.86002.</Citation><ArticleIdList><ArticleId IdType="doi">10.7554/eLife.86002</ArticleId><ArticleId IdType="pmc">PMC10032659</ArticleId><ArticleId IdType="pubmed">36947108</ArticleId></ArticleIdList></Reference><Reference><Citation>Yong SJ (2021). Long COVID or post-COVID-19 syndrome: putative pathophysiology, risk factors, and treatments. Infect. Dis. Lond. Engl 53, 737&#x2013;754.10.1080/23744235.2021.1924397.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/23744235.2021.1924397</ArticleId><ArticleId IdType="pmc">PMC8146298</ArticleId><ArticleId IdType="pubmed">34024217</ArticleId></ArticleIdList></Reference><Reference><Citation>Jansen EB, Orvold SN, Swan CL, Yourkowski A, Thivierge BM, Francis ME, Ge A, Rioux M, Darbellay J, Howland JG, et al. (2022). After the virus has cleared&#x2014;Can preclinical models be employed for Long COVID research? PLOS Pathog. 18, e1010741. 10.1371/journal.ppat.1010741.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1010741</ArticleId><ArticleId IdType="pmc">PMC9451097</ArticleId><ArticleId IdType="pubmed">36070309</ArticleId></ArticleIdList></Reference><Reference><Citation>Torres-Castro R, Vasconcello-Castillo L, Alsina-Restoy X, Solis-Navarro L, Burgos F, Puppo H, and Vilaro J (2021). Respiratory function in patients post-infection by COVID-19: a systematic review and meta-analysis. Pulmonology 27, 328&#x2013;337. 10.1016/j.pulmoe.2020.10.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pulmoe.2020.10.013</ArticleId><ArticleId IdType="pmc">PMC7687368</ArticleId><ArticleId IdType="pubmed">33262076</ArticleId></ArticleIdList></Reference><Reference><Citation>Du M, Ma Y, Deng J, Liu M, and Liu J (2022). Comparison of Long COVID-19 Caused by Different SARS-CoV-2 Strains: A Systematic Review and Meta-Analysis. Int. J. Environ. Res. Public. Health 19, 16010. 10.3390/ijerph192316010.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijerph192316010</ArticleId><ArticleId IdType="pmc">PMC9736973</ArticleId><ArticleId IdType="pubmed">36498103</ArticleId></ArticleIdList></Reference><Reference><Citation>Boufidou F, Medic S, Lampropoulou V, Siafakas N, Tsakris A, and Anastassopoulou C (2023). SARS-CoV-2 Reinfections and Long COVID in the Post-Omicron Phase of the Pandemic. Int. J. Mol. Sci 24, 12962. 10.3390/ijms241612962.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms241612962</ArticleId><ArticleId IdType="pmc">PMC10454552</ArticleId><ArticleId IdType="pubmed">37629143</ArticleId></ArticleIdList></Reference><Reference><Citation>Sansone F, Pellegrino GM, Caronni A, Bonazza F, Vegni E, Lu&#xe9; A, Bocci T, Pipolo C, Giusti G, Di Filippo P, et al. (2023). Long COVID in Children: A Multidisciplinary Review. Diagnostics 13, 1990. 10.3390/diagnostics13121990.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/diagnostics13121990</ArticleId><ArticleId IdType="pmc">PMC10297324</ArticleId><ArticleId IdType="pubmed">37370884</ArticleId></ArticleIdList></Reference><Reference><Citation>Covid-19 &#x201c;long haulers&#x201d; are organizing online to study themselves MIT Technol. Rev.   https://www.technologyreview.com/2020/08/12/1006602/covid-19-long-haulers-are-organizing-online-to-study-themselves/.</Citation></Reference><Reference><Citation>Callard F, and Perego E (2021). How and why patients made Long Covid. Soc. Sci. Med 1982 268, 113426. 10.1016/j.socscimed.2020.113426.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.socscimed.2020.113426</ArticleId><ArticleId IdType="pmc">PMC7539940</ArticleId><ArticleId IdType="pubmed">33199035</ArticleId></ArticleIdList></Reference><Reference><Citation>Lowenstein F (2020). Opinion | We Need to Talk About What Coronavirus Recoveries Look Like. N. Y. Times.</Citation></Reference><Reference><Citation>Yong E (2020). COVID-19 Can Last for Several Months. The Atlantic. https://www.theatlantic.com/health/archive/2020/06/covid-19-coronavirus-longterm-symptoms-months/612679/.</Citation></Reference><Reference><Citation>Yong E (2020). Long-Haulers Are Redefining COVID-19. The Atlantic. https://www.theatlantic.com/health/archive/2020/08/long-haulers-covid-19-recognition-support-groups-symptoms/615382/.</Citation></Reference><Reference><Citation>Report: What Does COVID-19 Recovery Actually Look Like? &#x2013; Patient Led Research Collaborative.   https://patientresearchcovid19.com/research/report-1/.</Citation></Reference><Reference><Citation>Chen C, Haupert SR, Zimmermann L, Shi X, Fritsche LG, and Mukherjee B (2022). Global Prevalence of Post-Coronavirus Disease 2019 (COVID-19) Condition or Long COVID: A Meta-Analysis and Systematic Review. J. Infect. Dis 226, 1593&#x2013;1607. 10.1093/infdis/jiac136.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/jiac136</ArticleId><ArticleId IdType="pmc">PMC9047189</ArticleId><ArticleId IdType="pubmed">35429399</ArticleId></ArticleIdList></Reference><Reference><Citation>Taquet M, Dercon Q, Luciano S, Geddes JR, Husain M, and Harrison PJ (2021). Incidence, co-occurrence, and evolution of long-COVID features: A 6-month retrospective cohort study of 273,618 survivors of COVID-19. PLoS Med. 18, e1003773. 10.1371/journal.pmed.1003773.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pmed.1003773</ArticleId><ArticleId IdType="pmc">PMC8478214</ArticleId><ArticleId IdType="pubmed">34582441</ArticleId></ArticleIdList></Reference><Reference><Citation>Antonelli M, Pujol JC, Spector TD, Ourselin S, and Steves CJ (2022). Risk of long COVID associated with delta versus omicron variants of SARS-CoV-2. Lancet Lond. Engl 399, 2263&#x2013;2264. 10.1016/S0140-6736(22)00941-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(22)00941-2</ArticleId><ArticleId IdType="pmc">PMC9212672</ArticleId><ArticleId IdType="pubmed">35717982</ArticleId></ArticleIdList></Reference><Reference><Citation>Ford ND (2023). Long COVID and Significant Activity Limitation Among Adults, by Age &#x2014; United States, June 1&#x2013;13, 2022, to June 7&#x2013;19, 2023. MMWR Morb. Mortal. Wkly. Rep 72. 10.15585/mmwr.mm7232a3.</Citation><ArticleIdList><ArticleId IdType="doi">10.15585/mmwr.mm7232a3</ArticleId><ArticleId IdType="pmc">PMC10415000</ArticleId><ArticleId IdType="pubmed">37561665</ArticleId></ArticleIdList></Reference><Reference><Citation>Products - Data Briefs - Number 480 - September 2023 (2023). 10.15620/cdc:132417.</Citation><ArticleIdList><ArticleId IdType="doi">10.15620/cdc:132417</ArticleId></ArticleIdList></Reference><Reference><Citation>Global Burden of Disease Long COVID Collaborators, Wulf Hanson S, Abbafati C, Aerts JG, Al-Aly Z, Ashbaugh C, Ballouz T, Blyuss O, Bobkova P, Bonsel G, et al. (2022). Estimated Global Proportions of Individuals With Persistent Fatigue, Cognitive, and Respiratory Symptom Clusters Following Symptomatic COVID-19 in 2020 and 2021. JAMA 328, 1604&#x2013;1615. 10.1001/jama.2022.18931.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2022.18931</ArticleId><ArticleId IdType="pmc">PMC9552043</ArticleId><ArticleId IdType="pubmed">36215063</ArticleId></ArticleIdList></Reference><Reference><Citation>Helmsdal G, Hanusson KD, Kristiansen MF, Foldbo BM, Danielsen ME, Steig BA, Gaini S, Strom M, Weihe P, and Petersen MS (2022). Long COVID in the Long Run-23-Month Follow-up Study of Persistent Symptoms. Open Forum Infect. Dis 9, ofac270. 10.1093/ofid/ofac270.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ofid/ofac270</ArticleId><ArticleId IdType="pmc">PMC9308378</ArticleId><ArticleId IdType="pubmed">35891696</ArticleId></ArticleIdList></Reference><Reference><Citation>Products - Data Briefs - Number 479 - September 2023 (2023). 10.15620/cdc:132416.</Citation><ArticleIdList><ArticleId IdType="doi">10.15620/cdc:132416</ArticleId></ArticleIdList></Reference><Reference><Citation>Lopez-Leon S, Wegman-Ostrosky T, Ayuzo Del Valle NC, Perelman C, Sepulveda R, Rebolledo PA, Cuapio A, and Villapol S (2022). Long-COVID in children and adolescents: a systematic review and meta-analyses. Sci. Rep 12, 9950. 10.1038/s41598-022-13495-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-022-13495-5</ArticleId><ArticleId IdType="pmc">PMC9226045</ArticleId><ArticleId IdType="pubmed">35739136</ArticleId></ArticleIdList></Reference><Reference><Citation>Rao S, Lee GM, Razzaghi H, Lorman V, Mejias A, Pajor NM, Thacker D, Webb R, Dickinson K, Bailey LC, et al. (2022). Clinical Features and Burden of Postacute Sequelae of SARS-CoV-2 Infection in Children and Adolescents. JAMA Pediatr. 176, 1000&#x2013;1009. 10.1001/jamapediatrics.2022.2800.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamapediatrics.2022.2800</ArticleId><ArticleId IdType="pmc">PMC9396470</ArticleId><ArticleId IdType="pubmed">35994282</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiang L, Li X, Nie J, Tang K, and Bhutta ZA (2023). A Systematic Review of Persistent Clinical Features After SARS-CoV-2 in the Pediatric Population. Pediatrics 152, e2022060351. 10.1542/peds.2022-060351.</Citation><ArticleIdList><ArticleId IdType="doi">10.1542/peds.2022-060351</ArticleId><ArticleId IdType="pmc">PMC10389775</ArticleId><ArticleId IdType="pubmed">37476923</ArticleId></ArticleIdList></Reference><Reference><Citation>Haddad A, Janda A, Renk H, Stich M, Frieh P, Kaier K, Lohrmann F, Nieters A, Willems A, Huzly D, et al. (2022). Long COVID symptoms in exposed and infected children, adolescents and their parents one year after SARS-CoV-2 infection: A prospective observational cohort study. eBioMedicine 84. 10.1016/j.ebiom.2022.104245.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ebiom.2022.104245</ArticleId><ArticleId IdType="pmc">PMC9495281</ArticleId><ArticleId IdType="pubmed">36155957</ArticleId></ArticleIdList></Reference><Reference><Citation>Zheng Y-B, Zeng N, Yuan K, Tian S-S, Yang Y-B, Gao N, Chen X, Zhang A-Y, Kondratiuk AL, Shi P-P, et al. (2023). Prevalence and risk factor for long COVID in children and adolescents: A meta-analysis and systematic review. J. Infect. Public Health 16, 660&#x2013;672. 10.1016/j.jiph.2023.03.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jiph.2023.03.005</ArticleId><ArticleId IdType="pmc">PMC9990879</ArticleId><ArticleId IdType="pubmed">36931142</ArticleId></ArticleIdList></Reference><Reference><Citation>Roge I, Smane L, Kivite-Urtane A, Pucuka Z, Racko I, Klavina L, and Pavare J (2021). Comparison of Persistent Symptoms After COVID-19 and Other Non-SARS-CoV-2 Infections in Children. Front. Pediatr 9, 752385. 10.3389/fped.2021.752385.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fped.2021.752385</ArticleId><ArticleId IdType="pmc">PMC8586002</ArticleId><ArticleId IdType="pubmed">34778143</ArticleId></ArticleIdList></Reference><Reference><Citation>Buonsenso D, Munblit D, De Rose C, Sinatti D, Ricchiuto A, Carfi A, and Valentini P (2021). Preliminary evidence on long COVID in children. Acta Paediatr. Oslo Nor 1992 110, 2208&#x2013;2211. 10.1111/apa.15870.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/apa.15870</ArticleId><ArticleId IdType="pmc">PMC8251440</ArticleId><ArticleId IdType="pubmed">33835507</ArticleId></ArticleIdList></Reference><Reference><Citation>Survivor Corps Surviv. Corps, https://www.survivorcorps.com.</Citation></Reference><Reference><Citation>Support, L.C.
Long Covid Support. Long Covid. https://www.longcovid.org/.</Citation></Reference><Reference><Citation>Patient Led Research Collaborative &#x2013; for Long COVID.   https://patientresearchcovid19.com/.</Citation></Reference><Reference><Citation>Long-Covid Europe | Long-Covid Europe; 
https://longcovideurope.org/.</Citation></Reference><Reference><Citation>Who We Are Long-COVID Alliance, https://longcovidalliance.org/home/about-us/.</Citation></Reference><Reference><Citation>Blog 2 covidCAREgroup.   https://www.covidcaregroup.org/recovery-tools.</Citation></Reference><Reference><Citation>Affairs (ASPA), A.S. for P. (2023). About Long COVID. https://www.covid.gov/be-informed/longcovid/about.</Citation></Reference><Reference><Citation>Soriano JB, Murthy S, Marshall JC, Relan P, Diaz JV, and WHO Clinical Case Definition Working Group on Post-COVID-19 Condition (2022). A clinical case definition of post-COVID-19 condition by a Delphi consensus. Lancet Infect. Dis 22, e102&#x2013;e107. 10.1016/S1473-3099(21)00703-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(21)00703-9</ArticleId><ArticleId IdType="pmc">PMC8691845</ArticleId><ArticleId IdType="pubmed">34951953</ArticleId></ArticleIdList></Reference><Reference><Citation>Thaweethai T, Jolley SE, Karlson EW, Levitan EB, Levy B, McComsey GA, McCorkell L, Nadkarni GN, Parthasarathy S, Singh U, et al. (2023). Development of a Definition of Postacute Sequelae of SARS-CoV-2 Infection. JAMA 329, 1934&#x2013;1946. 10.1001/jama.2023.8823.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2023.8823</ArticleId><ArticleId IdType="pmc">PMC10214179</ArticleId><ArticleId IdType="pubmed">37278994</ArticleId></ArticleIdList></Reference><Reference><Citation>Phetsouphanh C, Darley DR, Wlson DB, Howe A, Munier CML, Patel SK, Juno JA, Burrell LM, Kent SJ, Dore GJ, et al. (2022). Immunological dysfunction persists for 8 months following initial mild-to-moderate SARS-CoV-2 infection. Nat. Immunol 23, 210&#x2013;216. 10.1038/S41590-021-01113-X.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/S41590-021-01113-X</ArticleId><ArticleId IdType="pubmed">35027728</ArticleId></ArticleIdList></Reference><Reference><Citation>Peluso MJ, Deitchman AN, Torres L, Iyer NS, Munter SE, Nixon CC, Donatelli J, Thanh C, Takahashi S, Hakim J, et al. (2021). Long-term SARS-CoV-2-specific immune and inflammatory responses in individuals recovering from COVID-19 with and without postacute symptoms. Cell Rep. 36, 109518. 10.1016/j.celrep.2021.109518.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2021.109518</ArticleId><ArticleId IdType="pmc">PMC8342976</ArticleId><ArticleId IdType="pubmed">34358460</ArticleId></ArticleIdList></Reference><Reference><Citation>Littlefield KM, Watson RO, Schneider JM, Neff CP, Yamada E, Zhang M, Campbell TB, Falta MT, Jolley SE, Fontenot AP, et al. (2022). SARS-CoV-2-specific T cells associate with inflammation and reduced lung function in pulmonary post-acute sequalae of SARS-CoV-2. PLOS Pathog. 18, e1010359. 10.1371/journal.ppat.1010359.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1010359</ArticleId><ArticleId IdType="pmc">PMC9176759</ArticleId><ArticleId IdType="pubmed">35617421</ArticleId></ArticleIdList></Reference><Reference><Citation>Schulthei&#xdf; C, Wllscher E, Paschold L, Gottschick C, Klee B, Henkes S-S, Bosurgi L, Dutzmann J, Sedding D, Frese T, et al. (2022). The IL-1&#x3b2;, IL-6, and TNF cytokine triad is associated with post-acute sequelae of COVID-19. Cell Rep. Med 3, 100663. 10.1016/j.xcrm.2022.100663.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.xcrm.2022.100663</ArticleId><ArticleId IdType="pmc">PMC9214726</ArticleId><ArticleId IdType="pubmed">35732153</ArticleId></ArticleIdList></Reference><Reference><Citation>Su Y, Yuan D, Chen DG, Ng RH, Wang K, Choi J, Li S, Hong S, Zhang R, Xie J, et al. (2022). Multiple early factors anticipate post-acute COVID-19 sequelae. Cell 185, 881&#x2013;895.e20. 10.1016/j.cell.2022.01.014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2022.01.014</ArticleId><ArticleId IdType="pmc">PMC8786632</ArticleId><ArticleId IdType="pubmed">35216672</ArticleId></ArticleIdList></Reference><Reference><Citation>Scott NA, Pearmain L, Knight SB, Brand O, Morgan DJ, Jagger C, Harbach S, Khan S, Shuwa HA, Franklin M, et al. (2023). Monocyte migration profiles define disease severity in acute COVID-19 and unique features of long COVID. Eur. Respir. J 61, 2202226. 10.1183/13993003.02226-2022.</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/13993003.02226-2022</ArticleId><ArticleId IdType="pmc">PMC10040898</ArticleId><ArticleId IdType="pubmed">36922030</ArticleId></ArticleIdList></Reference><Reference><Citation>PHOSP-COVID Collaborative Group (2022). Clinical characteristics with inflammation profiling of long COVID and association with 1-year recovery following hospitalisation in the UK: a prospective observational study. Lancet Respir. Med 10, 761&#x2013;775. 10.1016/S2213-2600(22)00127-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(22)00127-8</ArticleId><ArticleId IdType="pmc">PMC9034855</ArticleId><ArticleId IdType="pubmed">35472304</ArticleId></ArticleIdList></Reference><Reference><Citation>Yin K, Peluso MJ, Luo X, Thomas R, Shin M-G, Neidleman J, Andrew A, Young KC, Ma T, Hoh R, et al. (2024). Long COVID manifests with T cell dysregulation, inflammation and an uncoordinated adaptive immune response to SARS-CoV-2. Nat. Immunol, 1&#x2013;8. 10.1038/s41590-023-01724-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41590-023-01724-6</ArticleId><ArticleId IdType="pmc">PMC10834368</ArticleId><ArticleId IdType="pubmed">38212464</ArticleId></ArticleIdList></Reference><Reference><Citation>Wong AC, Devason AS, Umana IC, Cox TO, Dohnalova L, Litichevskiy L, Perla J, Lundgren P, Etwebi Z, Izzo LT, et al. (2023). Serotonin reduction in post-acute sequelae of viral infection. Cell 0. 10.1016/j.cell.2023.09.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2023.09.013</ArticleId><ArticleId IdType="pmc">PMC11227373</ArticleId><ArticleId IdType="pubmed">37848036</ArticleId></ArticleIdList></Reference><Reference><Citation>Vijayakumar B, Boustani K, Ogger PP, Papadaki A, Tonkin J, Orton CM, Ghai P, Suveizdyte K, Hewitt RJ, Desai SR, et al. (2022). Immuno-proteomic profiling reveals aberrant immune cell regulation in the airways of individuals with ongoing post-COVID-19 respiratory disease. Immunity 55, 542&#x2013;556.e5. 10.1016/j.immuni.2022.01.017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2022.01.017</ArticleId><ArticleId IdType="pmc">PMC8789571</ArticleId><ArticleId IdType="pubmed">35151371</ArticleId></ArticleIdList></Reference><Reference><Citation>Visvabharathy L, Hanson BA, Orban ZS, Lim PH, Palacio NM, Jimenez M, Clark JR, Graham EL, Liotta EM, Tachas G, et al. (2023). Neuro-PASC is characterized by enhanced CD4+ and diminished CD8+ T cell responses to SARS-CoV-2 Nucleocapsid protein. Front. Immunol 14, 1155770. 10.3389/fimmu.2023.1155770.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2023.1155770</ArticleId><ArticleId IdType="pmc">PMC10258318</ArticleId><ArticleId IdType="pubmed">37313412</ArticleId></ArticleIdList></Reference><Reference><Citation>Klein J, Wood J, Jaycox JR, Dhodapkar RM, Lu P, Gehlhausen JR, Tabachnikova A, Greene K, Tabacof L, Malik AA, et al. (2023). Distinguishing features of long COVID identified through immune profiling. Nature 623, 139&#x2013;148. 10.1038/s41586-023-06651-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-023-06651-y</ArticleId><ArticleId IdType="pmc">PMC10620090</ArticleId><ArticleId IdType="pubmed">37748514</ArticleId></ArticleIdList></Reference><Reference><Citation>Swank Z, Senussi Y, Manickas-Hill Z, Yu XG, Li JZ, Alter G, and Walt DR (2023). Persistent Circulating Severe Acute Respiratory Syndrome Coronavirus 2 Spike Is Associated With Post-acute Coronavirus Disease 2019 Sequelae. Clin. Infect. Dis 76, e487&#x2013;e490. 10.1093/cid/ciac722.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciac722</ArticleId><ArticleId IdType="pmc">PMC10169416</ArticleId><ArticleId IdType="pubmed">36052466</ArticleId></ArticleIdList></Reference><Reference><Citation>Craddock V, Mahajan A, Spikes L, Krishnamachary B, Ram AK, Kumar A, Chen L, Chalise P, and Dhillon NK (2023). Persistent circulation of soluble and extracellular vesicle-linked Spike protein in individuals with postacute sequelae of COVID-19. J. Med. Virol 95, e28568. 10.1002/jmv.28568.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.28568</ArticleId><ArticleId IdType="pmc">PMC10048846</ArticleId><ArticleId IdType="pubmed">36756925</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis HE, Assaf GS, McCorkell L, Wei H, Low RJ, Re&#x2019;em Y, Redfield S, Austin JP, and Akrami A (2021). Characterizing long COVID in an international cohort: 7 months of symptoms and their impact. EClinicalMedicine 38, 101019. 10.1016/j.eclinm.2021.101019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2021.101019</ArticleId><ArticleId IdType="pmc">PMC8280690</ArticleId><ArticleId IdType="pubmed">34308300</ArticleId></ArticleIdList></Reference><Reference><Citation>Schulthei&#xdf; C, Willscher E, Paschold L, Gottschick C, Klee B, Bosurgi L, Dutzmann J, Sedding D, Frese T, Girndt M, et al. (2023). Liquid biomarkers of macrophage dysregulation and circulating spike protein illustrate the biological heterogeneity in patients with post-acute sequelae of COVID-19. J. Med. Virol 95, e28364. 10.1002/jmv.28364.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.28364</ArticleId><ArticleId IdType="pmc">PMC9878213</ArticleId><ArticleId IdType="pubmed">36458566</ArticleId></ArticleIdList></Reference><Reference><Citation>Thompson RC, Simons NW, Wilkins L, Cheng E, Del Valle DM, Hoffman GE, Cervia C, Fennessy B, Mouskas K, Francoeur NJ, et al. (2023). Molecular states during acute COVID-19 reveal distinct etiologies of long-term sequelae. Nat. Med 29, 236&#x2013;246. 10.1038/s41591-022-02107-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-022-02107-4</ArticleId><ArticleId IdType="pmc">PMC9873574</ArticleId><ArticleId IdType="pubmed">36482101</ArticleId></ArticleIdList></Reference><Reference><Citation>Peluso MJ, Deeks SG, Mustapic M, Kapogiannis D, Henrich TJ, Lu S, Goldberg SA, Hoh R, Chen JY, Martinez EO, et al. (2022). SARS-CoV-2 and Mitochondrial Proteins in Neural-Derived Exosomes of COVID-19. Ann. Neurol 91, 772&#x2013;781. 10.1002/ana.26350.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.26350</ArticleId><ArticleId IdType="pmc">PMC9082480</ArticleId><ArticleId IdType="pubmed">35285072</ArticleId></ArticleIdList></Reference><Reference><Citation>Reese JT, Blau H, Casiraghi E, Bergquist T, Loomba JJ, Callahan TJ, Laraway B, Antonescu C, Coleman B, Gargano M, et al. (2023). Generalisable long COVID subtypes: findings from the NIH N3C and RECOVER programmes. EBioMedicine 87, 104413. 10.1016/j.ebiom.2022.104413.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ebiom.2022.104413</ArticleId><ArticleId IdType="pmc">PMC9769411</ArticleId><ArticleId IdType="pubmed">36563487</ArticleId></ArticleIdList></Reference><Reference><Citation>Shuwa HA, Shaw TN, Knight SB, Wemyss K, McClure FA, Pearmain L, Prise I, Jagger C, Morgan DJ, Khan S, et al. (2021). Alterations in T and B cell function persist in convalescent COVID-19 patients. Med N. Y. N 2, 720&#x2013;735.e4. 10.1016/j.medj.2021.03.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.medj.2021.03.013</ArticleId><ArticleId IdType="pmc">PMC8011689</ArticleId><ArticleId IdType="pubmed">33821250</ArticleId></ArticleIdList></Reference><Reference><Citation>Ruffieux H, Hanson AL, Lodge S, Lawler NG, Whiley L, Gray N, Nolan TH, Bergamaschi L, Mescia F, Turner L, et al. (2023). A patient-centric modeling framework captures recovery from SARS-CoV-2 infection. Nat. Immunol 24, 349&#x2013;358. 10.1038/S41590-022-01380-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/S41590-022-01380-2</ArticleId><ArticleId IdType="pmc">PMC9892000</ArticleId><ArticleId IdType="pubmed">36717723</ArticleId></ArticleIdList></Reference><Reference><Citation>Talla A, Vasaikar SV, Szeto GL, Lemos MP, Czartoski JL, MacMillan H, Moodie Z, Cohen KW, Fleming LB, Thomson Z, et al. (2023). Persistent serum protein signatures define an inflammatory subcategory of long COVID. Nat. Commun 14, 3417. 10.1038/S41467-023-38682-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/S41467-023-38682-4</ArticleId><ArticleId IdType="pmc">PMC10252177</ArticleId><ArticleId IdType="pubmed">37296110</ArticleId></ArticleIdList></Reference><Reference><Citation>Antonelli M, Penfold RS, Merino J, Sudre CH, Molteni E, Berry S, Canas LS, Graham MS, Klaser K, Modat M, et al. (2021). Risk factors and disease profile of postvaccination SARS-CoV-2 infection in UK users of the COVID Symptom Study app: a prospective, community-based, nested, case-control study. Lancet Infect. Dis, S1473-3099(21)00460-6. 10.1016/S1473-3099(21)00460-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(21)00460-6</ArticleId><ArticleId IdType="pmc">PMC8409907</ArticleId><ArticleId IdType="pubmed">34480857</ArticleId></ArticleIdList></Reference><Reference><Citation>Brannock MD, Chew RF, Preiss AJ, Hadley EC, Redfield S, McMurry JA, Leese PJ, Girvin AT, Crosskey M, Zhou AG, et al. (2023). Long COVID risk and pre-COVID vaccination in an EHR-based cohort study from the RECOVER program. Nat. Commun 14, 2914. 10.1038/S41467-023-38388-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/S41467-023-38388-7</ArticleId><ArticleId IdType="pmc">PMC10201472</ArticleId><ArticleId IdType="pubmed">37217471</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuodi P, Gorelik Y, Zayyad H, Wertheim O, Wiegler KB, Abu Jabal K, Dror AA, Nazzal S, Glikman D, and Edelstein M (2022). Association between BNT162b2 vaccination and reported incidence of post-COVID-19 symptoms: cross-sectional study 2020-21, Israel. Npj Vaccines 7, 1&#x2013;8. 10.1038/s41541-022-00526-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41541-022-00526-5</ArticleId><ArticleId IdType="pmc">PMC9411827</ArticleId><ArticleId IdType="pubmed">36028498</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Aly Z, Bowe B, and Xie Y (2022). Long COVID after breakthrough SARS-CoV-2 infection. Nat. Med 28, 1461&#x2013;1467. 10.1038/s41591-022-01840-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-022-01840-0</ArticleId><ArticleId IdType="pmc">PMC9307472</ArticleId><ArticleId IdType="pubmed">35614233</ArticleId></ArticleIdList></Reference><Reference><Citation>Cortellini A, Tabernero J, Mukherjee U, Salazar R, Sureda A, Maluquer C, Ferrante D, Bower M, Sharkey R, Mirallas O, et al. (2023). SARS-CoV-2 omicron (B.1.1.529)-related COVID-19 sequelae in vaccinated and unvaccinated patients with cancer: results from the OnCovid registry. Lancet Oncol. 24, 335&#x2013;346. 10.1016/S1470-2045(23)00056-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1470-2045(23)00056-6</ArticleId><ArticleId IdType="pmc">PMC9991062</ArticleId><ArticleId IdType="pubmed">36898391</ArticleId></ArticleIdList></Reference><Reference><Citation>Zisis SN, Durieux JC, Mouchati C, Perez JA, and McComsey GA (2022). The Protective Effect of Coronavirus Disease 2019 (COVID-19) Vaccination on Postacute Sequelae of COVID-19: A Multicenter Study From a Large National Health Research Network. Open Forum Infect. Dis 9, ofac228. 10.1093/ofid/ofac228.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ofid/ofac228</ArticleId><ArticleId IdType="pmc">PMC9129153</ArticleId><ArticleId IdType="pubmed">35818362</ArticleId></ArticleIdList></Reference><Reference><Citation>Richard SA, Pollett SD, Fries AC, Berjohn CM, Maves RC, Lalani T, Smith AG, Mody RM, Ganesan A, Colombo RE, et al. (2023). Persistent COVID-19 Symptoms at 6 Months After Onset and the Role of Vaccination Before or After SARS-CoV-2 Infection. JAMA Netw. Open 6, e2251360. 10.1001/jamanetworkopen.2022.51360.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2022.51360</ArticleId><ArticleId IdType="pmc">PMC9857077</ArticleId><ArticleId IdType="pubmed">36652247</ArticleId></ArticleIdList></Reference><Reference><Citation>Ayoubkhani D, Bosworth ML, King S, Pouwels KB, Glickman M, Nafilyan V, Zaccardi F, Khunti K, Alwan NA, and Walker AS (2022). Risk of Long COVID in People Infected With Severe Acute Respiratory Syndrome Coronavirus 2 After 2 Doses of a Coronavirus Disease 2019 Vaccine: Community-Based, Matched Cohort Study. Open Forum Infect. Dis 9, ofac464. 10.1093/ofid/ofac464.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ofid/ofac464</ArticleId><ArticleId IdType="pmc">PMC9494414</ArticleId><ArticleId IdType="pubmed">36168555</ArticleId></ArticleIdList></Reference><Reference><Citation>Lundberg-Morris L, Leach S, Xu Y, Martikainen J, Santosa A, Gissl&#xe9;n M, Li H, Nyberg F, and Bygdell M (2023). Covid-19 vaccine effectiveness against post-covid-19 condition among 589 722 individuals in Sweden: population based cohort study. The BMJ 383, e076990. 10.1136/bmj-2023-076990.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj-2023-076990</ArticleId><ArticleId IdType="pmc">PMC10666099</ArticleId><ArticleId IdType="pubmed">37993131</ArticleId></ArticleIdList></Reference><Reference><Citation>Byambasuren O, Stehlik P, Clark J, Alcorn K, and Glasziou P (2023). Effect of covid-19 vaccination on long covid: systematic review. BMJ Med. 2, e000385. 10.1136/bmjmed-2022-000385.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjmed-2022-000385</ArticleId><ArticleId IdType="pmc">PMC9978692</ArticleId><ArticleId IdType="pubmed">36936268</ArticleId></ArticleIdList></Reference><Reference><Citation>Notarte KI, Catahay JA, Velasco JV, Pastrana A, Ver AT, Pangilinan FC, Peligro PJ, Casimiro M, Guerrero JJ, Gellaco MML, et al. (2022). Impact of COVID-19 vaccination on the risk of developing long-COVID and on existing long-COVID symptoms: A systematic review. EClinicalMedicine 53, 101624. 10.1016/j.eclinm.2022.101624.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2022.101624</ArticleId><ArticleId IdType="pmc">PMC9417563</ArticleId><ArticleId IdType="pubmed">36051247</ArticleId></ArticleIdList></Reference><Reference><Citation>MacCallum-Bridges C, Hirschtick JL, Patel A, Orellana RC, Elliott MR, and Fleischer NL (2024). The impact of COVID-19 vaccination prior to SARS-CoV-2 infection on prevalence of long COVID among a population-based probability sample of Michiganders, 2020-2022. Ann. Epidemiol 92, 17&#x2013;24. 10.1016/j.annepidem.2024.02.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.annepidem.2024.02.007</ArticleId><ArticleId IdType="pubmed">38382771</ArticleId></ArticleIdList></Reference><Reference><Citation>Razzaghi H, Forrest CB, Hirabayashi K, Wu Q, Allen A, Rao S, Chen Y, Bunnell HT, Chrischilles EA, Cowell LG, et al. (2024). Vaccine Effectiveness Against Long COVID in Children. Pediatrics. 10.1542/peds.2023-064446.</Citation><ArticleIdList><ArticleId IdType="doi">10.1542/peds.2023-064446</ArticleId><ArticleId IdType="pmc">PMC10979300</ArticleId><ArticleId IdType="pubmed">38225804</ArticleId></ArticleIdList></Reference><Reference><Citation>Xie Y, Choi T, and Al-Aly Z (2023). Association of Treatment With Nirmatrelvir and the Risk of Post-COVID-19 Condition. JAMA Intern. Med 183, 554&#x2013;564.10.1001/jamainternmed.2023.0743.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamainternmed.2023.0743</ArticleId><ArticleId IdType="pmc">PMC10037200</ArticleId><ArticleId IdType="pubmed">36951829</ArticleId></ArticleIdList></Reference><Reference><Citation>Xie Y, Choi T, and Al-Aly Z (2023). Molnupiravir and risk of post-acute sequelae of covid-19: cohort study. BMJ 381, e074572. 10.1136/bmj-2022-074572.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj-2022-074572</ArticleId><ArticleId IdType="pmc">PMC10126525</ArticleId><ArticleId IdType="pubmed">37161995</ArticleId></ArticleIdList></Reference><Reference><Citation>Fung KW, Baye F, Baik SH, and McDonald CJ (2023). Nirmatrelvir and Molnupiravir and Post-COVID-19 Condition in Older Patients. JAMA Intern. Med 183, 1404&#x2013;1406. 10.1001/jamainternmed.2023.5099.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamainternmed.2023.5099</ArticleId><ArticleId IdType="pmc">PMC10594174</ArticleId><ArticleId IdType="pubmed">37870856</ArticleId></ArticleIdList></Reference><Reference><Citation>Congdon S, Narrowe Z, Yone N, Gunn J, Deng Y, Nori P, Cowman K, Islam M, Rikin S, and Starrels J (2023). Nirmatrelvir/ritonavir and risk of long COVID symptoms: a retrospective cohort study. Sci. Rep 13, 19688. 10.1038/s41598-023-46912-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-023-46912-4</ArticleId><ArticleId IdType="pmc">PMC10640584</ArticleId><ArticleId IdType="pubmed">37951998</ArticleId></ArticleIdList></Reference><Reference><Citation>Boglione L, Meli G, Poletti F, Rostagno R, Moglia R, Cantone M, Esposito M, Scianguetta C, Domenicale B, Di Pasquale F, et al. (2022). Risk factors and incidence of long-COVID syndrome in hospitalized patients: does remdesivir have a protective effect? QJM Mon. J. Assoc. Physicians 114, 865&#x2013;871. 10.1093/qjmed/hcab297.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/qjmed/hcab297</ArticleId><ArticleId IdType="pmc">PMC8690187</ArticleId><ArticleId IdType="pubmed">34850210</ArticleId></ArticleIdList></Reference><Reference><Citation>Nevalainen OPO, Horstia S, Laakkonen S, Rutanen J, Mustonen JMJ, Kalliala IEJ, Ansakorpi H, Kreivi H-R, Kuutti P, Paajanen J, et al. (2022). Effect of remdesivir post hospitalization for COVID-19 infection from the randomized SOLIDARITY Finland trial. Nat. Commun 13, 6152. 10.1038/s41467-022-33825-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-022-33825-5</ArticleId><ArticleId IdType="pmc">PMC9579198</ArticleId><ArticleId IdType="pubmed">36257950</ArticleId></ArticleIdList></Reference><Reference><Citation>Bramante CT, Buse JB, Liebovitz DM, Nicklas JM, Puskarich MA, Cohen K, Belani HK, Anderson BJ, Huling JD, Tignanelli CJ, et al. (2023). Outpatient treatment of COVID-19 and incidence of post-COVID-19 condition over 10 months (COVID-OUT): a multicentre, randomised, quadruple-blind, parallel-group, phase 3 trial. Lancet Infect. Dis 23, 1119&#x2013;1129. 10.1016/S1473-3099(23)00299-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(23)00299-2</ArticleId><ArticleId IdType="pmc">PMC11259948</ArticleId><ArticleId IdType="pubmed">37302406</ArticleId></ArticleIdList></Reference><Reference><Citation>Ely W (2023). REVERSE-Long COVID: A Multicenter Randomized, Placebo-Controlled Clinical Trial of Immunomodulation (With Baricitinib) for Long COVID Related Cognitive Impairment and ADRD (Alzheimer&#x2019;s Disease and Related Dementias)-Pilot Study (clinicaltrials.gov).</Citation></Reference><Reference><Citation>Derby: New anti-viral drug study aims to cure long Covid (2023).</Citation></Reference><Reference><Citation>McCarthy MW (2023). Paxlovid as a potential treatment for long COVID. Expert Opin. Pharmacother 24, 1839&#x2013;1843. 10.1080/14656566.2023.2262387.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/14656566.2023.2262387</ArticleId><ArticleId IdType="pubmed">37731377</ArticleId></ArticleIdList></Reference><Reference><Citation>Bowe B, Xie Y, and Al-Aly Z (2022). Acute and postacute sequelae associated with SARS-CoV-2 reinfection. Nat. Med 28, 2398&#x2013;2405. 10.1038/s41591-022-02051-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-022-02051-3</ArticleId><ArticleId IdType="pmc">PMC9671810</ArticleId><ArticleId IdType="pubmed">36357676</ArticleId></ArticleIdList></Reference><Reference><Citation>Hadley E, Yoo YJ, Patel S, Zhou A, Laraway B, Wong R, Preiss A, Chew R, Davis H, Chute CG, et al. (2023). SARS-CoV-2 Reinfection is Preceded by Unique Biomarkers and Related to Initial Infection Timing and Severity: an N3C RECOVER EHR-Based Cohort Study. Preprint at medRxiv, 10.1101/2023.01.03.22284042 10.1101/2023.01.03.22284042.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2023.01.03.22284042</ArticleId></ArticleIdList></Reference><Reference><Citation>Willan J, Agarwal G, and Bienz N (2023). Mortality and burden of post-COVID-19 syndrome have reduced with time across SARS-CoV-2 variants in haematology patients. Br. J. Haematol 201, 640&#x2013;644. 10.1111/bjh.18700.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/bjh.18700</ArticleId><ArticleId IdType="pubmed">36861893</ArticleId></ArticleIdList></Reference><Reference><Citation>Kahlert CR, Strahm C, G&#xfc;sewell S, Cusini A, Brucher A, Goppel S, M&#xf6;ller E, M&#xf6;ller JC, Ortner M, Ruetti M, et al. (2023). Post-Acute Sequelae After Severe Acute Respiratory Syndrome Coronavirus 2 Infection by Viral Variant and Vaccination Status: A Multicenter Cross-Sectional Study. Clin. Infect. Dis 77, 194&#x2013;202. 10.1093/cid/ciad143.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciad143</ArticleId><ArticleId IdType="pmc">PMC10371307</ArticleId><ArticleId IdType="pubmed">36905145</ArticleId></ArticleIdList></Reference><Reference><Citation>Hedberg P, and Naucl&#xe9;r P (2023). Post-COVID-19 Condition After SARS-CoV-2 Infections During the Omicron Surge vs the Delta, Alpha, and Wild Type Periods in Stockholm, Sweden. J. Infect. Dis, jiad382. 10.1093/infdis/jiad382.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/jiad382</ArticleId><ArticleId IdType="pmc">PMC10786247</ArticleId><ArticleId IdType="pubmed">37665981</ArticleId></ArticleIdList></Reference><Reference><Citation>Gottlieb M, Wang RC, Yu H, Spatz ES, Montoy JCC, Rodriguez RM, Chang AM, Elmore JG, Hannikainen PA, Hill M, et al. (2023). Severe Fatigue and Persistent Symptoms at 3 Months Following Severe Acute Respiratory Syndrome Coronavirus 2 Infections During the Pre-Delta, Delta, and Omicron Time Periods: A Multicenter Prospective Cohort Study. Clin. Infect. Dis. Off. Publ. Infect. Dis. Soc. Am 76, 1930&#x2013;1941. 10.1093/cid/ciad045.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciad045</ArticleId><ArticleId IdType="pmc">PMC10249989</ArticleId><ArticleId IdType="pubmed">36705268</ArticleId></ArticleIdList></Reference><Reference><Citation>P&#xe9;rez-G&#xf3;mez A, Vitall&#xe9; J, Gasca-Capote C, Gutierrez-Valencia A, Trujillo-Rodriguez M, Serna-Gallego A, Mu&#xf1;oz-Muela E, Jim&#xe9;nez-Leon M. de L.R., Rafii-El-Idrissi Benhnia M, Rivas-Jeremias I, et al. (2021). Dendritic cell deficiencies persist seven months after SARS-CoV-2 infection. Cell. Mol. Immunol 18, 2128&#x2013;2139. 10.1038/s41423-021-00728-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41423-021-00728-2</ArticleId><ArticleId IdType="pmc">PMC8294321</ArticleId><ArticleId IdType="pubmed">34290398</ArticleId></ArticleIdList></Reference><Reference><Citation>Townsend L, Dyer AH, Naughton A, Kiersey R, Holden D, Gardiner M, Dowds J, O&#x2019;Brien K, Bannan C, Nadarajan P, et al. (2021). Longitudinal Analysis of COVID-19 Patients Shows Age-Associated T Cell Changes Independent of Ongoing Ill-Health. Front. Immunol 12, 676932. 10.3389/fimmu.2021.676932.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.676932</ArticleId><ArticleId IdType="pmc">PMC8138306</ArticleId><ArticleId IdType="pubmed">34025675</ArticleId></ArticleIdList></Reference><Reference><Citation>Wiech M, Chroscicki P, Swatler J, Stepnik D, De Biasi S, Hampel M, Brewinska-Olchowik M, Maliszewska A, Sklinda K, Durlik M, et al. (2022). Remodeling of T Cell Dynamics During Long COVID Is Dependent on Severity of SARS-CoV-2 Infection. Front. Immunol 13, 886431. 10.3389/fimmu.2022.886431.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2022.886431</ArticleId><ArticleId IdType="pmc">PMC9226563</ArticleId><ArticleId IdType="pubmed">35757700</ArticleId></ArticleIdList></Reference><Reference><Citation>Hopkins FR, Govender M, Svanberg C, Nordgren J, Waller H, Nilsdotter-Augustinsson &#xc5;, Henningsson AJ, Hagbom M, Sj&#xf6;wall J, Nystr&#xf6;m S, et al. (2022). Major alterations to monocyte and dendritic cell subsets lasting more than 6 months after hospitalization for COVID-19. Front. Immunol 13, 1082912. 10.3389/fimmu.2022.1082912.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2022.1082912</ArticleId><ArticleId IdType="pmc">PMC9846644</ArticleId><ArticleId IdType="pubmed">36685582</ArticleId></ArticleIdList></Reference><Reference><Citation>Captur G, Moon JC, Topriceanu C-C, Joy G, Swadling L, Hallqvist J, Doykov I, Patel N, Spiewak J, Baldwin T, et al. (2022). Plasma proteomic signature predicts who will get persistent symptoms following SARS-CoV-2 infection. EBioMedicine 85, 104293. 10.1016/j.ebiom.2022.104293.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ebiom.2022.104293</ArticleId><ArticleId IdType="pmc">PMC9515404</ArticleId><ArticleId IdType="pubmed">36182629</ArticleId></ArticleIdList></Reference><Reference><Citation>Doykov I, H&#xe4;llqvist J, Gilmour KC, Grandjean L, Mills K, and Heywood WE (2020). &#x201c;The long tail of Covid-19&#x201d; - The detection of a prolonged inflammatory response after a SARS-CoV-2 infection in asymptomatic and mildly affected patients. F1000Research 9, 1349. 10.12688/f1000research.27287.2.</Citation><ArticleIdList><ArticleId IdType="doi">10.12688/f1000research.27287.2</ArticleId><ArticleId IdType="pmc">PMC7745182</ArticleId><ArticleId IdType="pubmed">33391730</ArticleId></ArticleIdList></Reference><Reference><Citation>Fern&#xe1;ndez-Casta&#xf1;eda A, Lu P, Geraghty AC, Song E, Lee M-H, Wood J, O&#x2019;Dea MR, Dutton S, Shamardani K, Nwangwu K, et al. (2022). Mild respiratory COVID can cause multi-lineage neural cell and myelin dysregulation. Cell 185, 2452&#x2013;2468.e16. 10.1016/j.cell.2022.06.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2022.06.008</ArticleId><ArticleId IdType="pmc">PMC9189143</ArticleId><ArticleId IdType="pubmed">35768006</ArticleId></ArticleIdList></Reference><Reference><Citation>Ong SWX, Fong S-W, Young BE, Chan Y-H, Lee B, Amrun SN, Chee RS-L, Yeo NK-W, Tambyah P, Pada S, et al. (2021). Persistent Symptoms and Association With Inflammatory Cytokine Signatures in Recovered Coronavirus Disease 2019 Patients. Open Forum Infect. Dis 8, ofab156. 10.1093/ofid/ofab156.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ofid/ofab156</ArticleId><ArticleId IdType="pmc">PMC8083585</ArticleId><ArticleId IdType="pubmed">34095336</ArticleId></ArticleIdList></Reference><Reference><Citation>Marchi M, Grenzi P, Serafini V, Capoccia F, Rossi F, Marrino P, Pingani L, Galeazzi GM, and Ferrari S (2023). Psychiatric symptoms in Long-COVID patients: a systematic review. Front. Psychiatry 14. 10.3389/fpsyt.2023.1138389.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fpsyt.2023.1138389</ArticleId><ArticleId IdType="pmc">PMC10320160</ArticleId><ArticleId IdType="pubmed">37415689</ArticleId></ArticleIdList></Reference><Reference><Citation>Marazziti D (2017). Understanding the role of serotonin in psychiatric diseases. F1000Research 6, 180. 10.12688/f1000research.10094.1.</Citation><ArticleIdList><ArticleId IdType="doi">10.12688/f1000research.10094.1</ArticleId><ArticleId IdType="pmc">PMC5325064</ArticleId><ArticleId IdType="pubmed">28299200</ArticleId></ArticleIdList></Reference><Reference><Citation>Sadlier C, Albrich WC, Neogi U, Lunjani N, Horgan M, O&#x2019;Toole PW, and O&#x2019;Mahony L (2022). Metabolic rewiring and serotonin depletion in patients with postacute sequelae of COVID-19. Allergy 77, 1623&#x2013;1625. 10.1111/all.15253.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/all.15253</ArticleId><ArticleId IdType="pmc">PMC9111264</ArticleId><ArticleId IdType="pubmed">35150456</ArticleId></ArticleIdList></Reference><Reference><Citation>Peghin M, Palese A, Venturini M, De Martino M, Gerussi V, Graziano E, Bontempo G, Marrella F, Tommasini A, Fabris M, et al. (2021). Post-COVID-19 symptoms 6 months after acute infection among hospitalized and non-hospitalized patients. Clin. Microbiol. Infect. Off. Publ. Eur. Soc. Clin. Microbiol. Infect. Dis 27, 1507&#x2013;1513. 10.1016/j.cmi.2021.05.033.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmi.2021.05.033</ArticleId><ArticleId IdType="pmc">PMC8180450</ArticleId><ArticleId IdType="pubmed">34111579</ArticleId></ArticleIdList></Reference><Reference><Citation>Gaebler C, Wang Z, Lorenzi JCC, Muecksch F, Finkin S, Tokuyama M, Cho A, Jankovic M, Schaefer-Babajew D, Oliveira TY, et al. (2021). Evolution of antibody immunity to SARS-CoV-2. Nature 591, 639&#x2013;644. 10.1038/s41586-021-03207-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-021-03207-w</ArticleId><ArticleId IdType="pmc">PMC8221082</ArticleId><ArticleId IdType="pubmed">33461210</ArticleId></ArticleIdList></Reference><Reference><Citation>Garcia-Abell&#xe1;n J, Fern&#xe1;ndez M, Padilla S, Garcia JA, Agull&#xf3; V, Lozano V, Ena N, Garcia-S&#xe1;nchez L, Guti&#xe9;rrez F, and Masi&#xe1; M (2022). Immunologic phenotype of patients with long-COVID syndrome of 1-year duration. Front. Immunol 13, 920627. 10.3389/fimmu.2022.920627.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2022.920627</ArticleId><ArticleId IdType="pmc">PMC9451924</ArticleId><ArticleId IdType="pubmed">36090973</ArticleId></ArticleIdList></Reference><Reference><Citation>Pereira C, Harris BHL, Di Giovannantonio M, Rosadas C, Short C-E, Quinlan R, Sureda-Vives M, Fernandez N, Day-Weber I, Khan M, et al. (2021). The Association Between Antibody Response to Severe Acute Respiratory Syndrome Coronavirus 2 Infection and Post-COVID-19 Syndrome in Healthcare Workers. J. Infect. Dis 223, 1671&#x2013;1676. 10.1093/infdis/jiab120.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/jiab120</ArticleId><ArticleId IdType="pmc">PMC7989400</ArticleId><ArticleId IdType="pubmed">33675366</ArticleId></ArticleIdList></Reference><Reference><Citation>Lingel H, Meltendorf S, Billing U, Thurm C, Vogel K, Majer C, Pr&#xe4;tsch F, Roggenbuck D, Heuft H-G, Hachenberg T, et al. (2021). Unique autoantibody prevalence in long-term recovered SARS-CoV-2-infected individuals. J. Autoimmun 122, 102682. 10.1016/j.jaut.2021.102682.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaut.2021.102682</ArticleId><ArticleId IdType="pmc">PMC8214939</ArticleId><ArticleId IdType="pubmed">34214763</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee ECY, Tyler RE, Johnson D, Koh N, Ong BC, Foo SY, and Tan JWC (2022). High frequency of anti-DSG 2 antibodies in post COVID-19 serum samples. J. Mol. Cell. Cardiol 170, 121&#x2013;123. 10.1016/j.yjmcc.2022.06.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.yjmcc.2022.06.006</ArticleId><ArticleId IdType="pmc">PMC9233549</ArticleId><ArticleId IdType="pubmed">35764120</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Y, Ebinger JE, Mostafa R, Budde P, Gajewski J, Walker B, Joung S, Wu M, Br&#xe4;utigam M, Hesping F, et al. (2021). Paradoxical sex-specific patterns of autoantibody response to SARS-CoV-2 infection. J. Transl. Med 19, 524. 10.1186/s12967-021-03184-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12967-021-03184-8</ArticleId><ArticleId IdType="pmc">PMC8716184</ArticleId><ArticleId IdType="pubmed">34965855</ArticleId></ArticleIdList></Reference><Reference><Citation>Wallukat G, Hohberger B, Wenzel K, F&#xfc;rst J, Schulze-Rothe S, Wallukat A, H&#xf6;nicke A-S, and M&#xfc;ller J (2021). Functional autoantibodies against G-protein coupled receptors in patients with persistent Long-COVID-19 symptoms. J. Transl. Autoimmun 4, 100100. 10.1016/j.jtauto.2021.100100.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jtauto.2021.100100</ArticleId><ArticleId IdType="pmc">PMC8049853</ArticleId><ArticleId IdType="pubmed">33880442</ArticleId></ArticleIdList></Reference><Reference><Citation>Son K, Jamil R, Chowdhury A, Mukherjee M, Venegas C, Miyasaki K, Zhang K, Patel Z, Salter B, Yuen ACY, et al. (2023). Circulating anti-nuclear autoantibodies in COVID-19 survivors predict long COVID symptoms. Eur. Respir. J 61, 2200970. 10.1183/13993003.00970-2022.</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/13993003.00970-2022</ArticleId><ArticleId IdType="pmc">PMC9515477</ArticleId><ArticleId IdType="pubmed">36137590</ArticleId></ArticleIdList></Reference><Reference><Citation>Bodansky A, Wang C-Y, Saxena A, Mitchell A, Kung AF, Takahashi S, Anglin K, Huang B, Hoh R, Lu S, et al. (2023). Autoantigen profiling reveals a shared post-COVID signature in fully recovered and long COVID patients. JCI Insight 8, e169515. 10.1172/jci.insight.169515.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/jci.insight.169515</ArticleId><ArticleId IdType="pmc">PMC10393220</ArticleId><ArticleId IdType="pubmed">37288661</ArticleId></ArticleIdList></Reference><Reference><Citation>Griffin DE (2022). Why does viral RNA sometimes persist after recovery from acute infections? PLOS Biol. 20, e3001687. 10.1371/journal.pbio.3001687.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pbio.3001687</ArticleId><ArticleId IdType="pmc">PMC9191737</ArticleId><ArticleId IdType="pubmed">35648781</ArticleId></ArticleIdList></Reference><Reference><Citation>Stein SR, Ramelli SC, Grazioli A, Chung J-Y, Singh M, Yinda CK, Winkler CW, Sun J, Dickey JM, Ylaya K, et al. (2022). SARS-CoV-2 infection and persistence in the human body and brain at autopsy. Nature 612, 758&#x2013;763. 10.1038/s41586-022-05542-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-022-05542-y</ArticleId><ArticleId IdType="pmc">PMC9749650</ArticleId><ArticleId IdType="pubmed">36517603</ArticleId></ArticleIdList></Reference><Reference><Citation>Rendeiro AF, Ravichandran H, Kim J, Borczuk AC, Elemento O, and Schwartz RE (2022). Persistent alveolar type 2 dysfunction and lung structural derangement in postacute COVID-19. MedRxiv Prepr. Serv. Health Sci, 2022.11.28.22282811. 10.1101/2022.11.28.22282811.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2022.11.28.22282811</ArticleId></ArticleIdList></Reference><Reference><Citation>Roden AC, Boland JM, Johnson TF, Aubry MC, Lo Y-C, Butt YM, Maleszewski JJ, Larsen BT, Tazelaar HD, Khoor A, et al. (2022). Late Complications of COVID-19: A Morphologic, Imaging, and Droplet Digital Polymerase Chain Reaction Study of Lung Tissue. Arch. Pathol. Lab. Med 146, 791&#x2013;804. 10.5858/arpa.2021-0519-SA.</Citation><ArticleIdList><ArticleId IdType="doi">10.5858/arpa.2021-0519-SA</ArticleId><ArticleId IdType="pubmed">35319744</ArticleId></ArticleIdList></Reference><Reference><Citation>Hany M, Zidan A, Gaballa M, Ibrahim M, Agayby ASS, Abouelnasr AA, Sheta E, and Torensma B (2023). Lingering SARS-CoV-2 in Gastric and Gallbladder Tissues of Patients with Previous COVID-19 Infection Undergoing Bariatric Surgery. Obes. Surg 33, 139&#x2013;148. 10.1007/s11695-022-06338-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11695-022-06338-9</ArticleId><ArticleId IdType="pmc">PMC9628579</ArticleId><ArticleId IdType="pubmed">36316598</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheung CCL, Goh D, Lim X, Tien TZ, Lim JCT, Lee JN, Tan B, Tay ZEA, Wan WY, Chen EX, et al. (2022). Residual SARS-CoV-2 viral antigens detected in GI and hepatic tissues from five recovered patients with COVID-19. Gut 71, 226&#x2013;229. 10.1136/gutjnl-2021-324280.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/gutjnl-2021-324280</ArticleId><ArticleId IdType="pubmed">34083386</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu Q, Milanez-Almeida P, Martins AJ, Radtke AJ, Hoehn KB, Oguz C, Chen J, Liu C, Tang J, Grubbs G, et al. (2023). Adaptive immune responses to SARS-CoV-2 persist in the pharyngeal lymphoid tissue of children. Nat. Immunol 24, 186&#x2013;199. 10.1038/S41590-022-01367-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/S41590-022-01367-z</ArticleId><ArticleId IdType="pmc">PMC10777159</ArticleId><ArticleId IdType="pubmed">36536106</ArticleId></ArticleIdList></Reference><Reference><Citation>Tejerina F, Catalan P, Rodriguez-Grande C, Adan J, Rodriguez-Gonzalez C, Mu&#xf1;oz P, Aldamiz T, Diez C, Perez L, Fanciulli C, et al. (2022). Post-COVID-19 syndrome. SARS-CoV-2 RNA detection in plasma, stool, and urine in patients with persistent symptoms after COVID-19. BMC Infect. Dis 22, 211. 10.1186/s12879-022-07153-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12879-022-07153-4</ArticleId><ArticleId IdType="pmc">PMC8892394</ArticleId><ArticleId IdType="pubmed">35240997</ArticleId></ArticleIdList></Reference><Reference><Citation>Goh D, Lim JCT, Fernaindez SB, Joseph CR, Edwards SG, Neo ZW, Lee JN, Caballero SG, Lau MC, and Yeong JPS (2022). Case report: Persistence of residual antigen and RNA of the SARS-CoV-2 virus in tissues of two patients with long COVID. Front. Immunol 13, 939989. 10.3389/fimmu.2022.939989.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2022.939989</ArticleId><ArticleId IdType="pmc">PMC9483160</ArticleId><ArticleId IdType="pubmed">36131932</ArticleId></ArticleIdList></Reference><Reference><Citation>Peluso MJ, Ryder D, Flavell R, Wang Y, Levi J, LaFranchi BH, Deveau T-M, Buck AM, Munter SE, Asare KA, et al. (2023). Multimodal Molecular Imaging Reveals Tissue-Based T Cell Activation and Viral RNA Persistence for Up to 2 Years Following COVID-19. Preprint at medRxiv, 10.1101/2023.07.27.23293177 10.1101/2023.07.27.23293177.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2023.07.27.23293177</ArticleId></ArticleIdList></Reference><Reference><Citation>Zollner A, Koch R, Jukic A, Pfister A, Meyer M, R&#xf6;ssler A, Kimpel J, Adolph TE, and Tilg H (2022). Postacute COVID-19 is Characterized by Gut Viral Antigen Persistence in Inflammatory Bowel Diseases. Gastroenterology 163, 495&#x2013;506.e8. 10.1053/j.gastro.2022.04.037.</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.gastro.2022.04.037</ArticleId><ArticleId IdType="pmc">PMC9057012</ArticleId><ArticleId IdType="pubmed">35508284</ArticleId></ArticleIdList></Reference><Reference><Citation>de Melo GD, Lazarini F, Levallois S, Hautefort C, Michel V, Larrous F, Verillaud B, Aparicio C, Wagner S, Gheusi G, et al. (2021). COVID-19-related anosmia is associated with viral persistence and inflammation in human olfactory epithelium and brain infection in hamsters. Sci. Transl. Med 13, eabf8396. 10.1126/scitranslmed.abf8396.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/scitranslmed.abf8396</ArticleId><ArticleId IdType="pmc">PMC8158965</ArticleId><ArticleId IdType="pubmed">33941622</ArticleId></ArticleIdList></Reference><Reference><Citation>Yao Q, Doyle ME, Liu Q-R, Appleton A, O&#x2019;Connell JF, Weng N, and Egan JM (2023). Long-Term Dysfunction of Taste Papillae in SARS-CoV-2. NEJM Evid. 2, EVIDoa2300046. 10.1056/EVIDoa2300046.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/EVIDoa2300046</ArticleId><ArticleId IdType="pmc">PMC10745124</ArticleId><ArticleId IdType="pubmed">38145006</ArticleId></ArticleIdList></Reference><Reference><Citation>Lima T.M. de, Martins RB, Miura CS, Souza MVO, Cassiano MHA, Rodrigues TS, Veras FP, Sousa J. de F., Gomes R, Almeida G.M. de, et al. (2023). Tonsils are major sites of persistence of SARS-CoV-2 in children. Microbiol. Spectr 11, e0134723. 10.1128/spectrum.01347-23.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/spectrum.01347-23</ArticleId><ArticleId IdType="pmc">PMC10581087</ArticleId><ArticleId IdType="pubmed">37737615</ArticleId></ArticleIdList></Reference><Reference><Citation>Peluso MJ, Swank ZN, Goldberg SA, Lu S, Dalhuisen T, Borberg E, Senussi Y, Luna MA, Chang Song C, Clark A, et al. (2023). Plasma-based antigen persistence in the post-acute phase of SARS-CoV-2 infection. MedRxiv Prepr. Serv. Health Sci, 2023.10.24.23297114. 10.1101/2023.10.24.23297114.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2023.10.24.23297114</ArticleId><ArticleId IdType="pubmed">38604216</ArticleId></ArticleIdList></Reference><Reference><Citation>Natarajan A, Zlitni S, Brooks EF, Vance SE, Dahlen A, Hedlin H, Park RM, Han A, Schmidtke DT, Verma R, et al. (2022). Gastrointestinal symptoms and fecal shedding of SARS-CoV-2 RNA suggest prolonged gastrointestinal infection. Med N. Y. N 3, 371&#x2013;387.e9. 10.1016/j.medj.2022.04.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.medj.2022.04.001</ArticleId><ArticleId IdType="pmc">PMC9005383</ArticleId><ArticleId IdType="pubmed">35434682</ArticleId></ArticleIdList></Reference><Reference><Citation>Chan JF-W, Zhang AJ, Yuan S, Poon VK-M, Chan CC-S, Lee AC-Y, Chan W-M, Fan Z, Tsoi H-W, Wen L, et al. (2020). Simulation of the Clinical and Pathological Manifestations of Coronavirus Disease 2019 (COVID-19) in a Golden Syrian Hamster Model: Implications for Disease Pathogenesis and Transmissibility. Clin. Infect. Dis. Off. Publ. Infect. Dis. Soc. Am 71, 2428&#x2013;2446. 10.1093/cid/ciaa325.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciaa325</ArticleId><ArticleId IdType="pmc">PMC7184405</ArticleId><ArticleId IdType="pubmed">32215622</ArticleId></ArticleIdList></Reference><Reference><Citation>Francis ME, Goncin U, Kroeker A, Swan C, Ralph R, Lu Y, Etzioni AL, Falzarano D, Gerdts V, Machtaler S, et al. (2021). SARS-CoV-2 infection in the Syrian hamster model causes inflammation as well as type I interferon dysregulation in both respiratory and non-respiratory tissues including the heart and kidney. PLoS Pathog. 17, e1009705. 10.1371/journal.ppat.1009705.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1009705</ArticleId><ArticleId IdType="pmc">PMC8282065</ArticleId><ArticleId IdType="pubmed">34265022</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoagland DA, M&#xf6;ller R, Uhl SA, Oishi K, Frere J, Golynker I, Horiuchi S, Panis M, Blanco-Melo D, Sachs D, et al. (2021). Leveraging the antiviral type I interferon system as a first line of defense against SARS-CoV-2 pathogenicity. Immunity 54, 557&#x2013;570.e5. 10.1016/j.immuni.2021.01.017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2021.01.017</ArticleId><ArticleId IdType="pmc">PMC7846242</ArticleId><ArticleId IdType="pubmed">33577760</ArticleId></ArticleIdList></Reference><Reference><Citation>Song Z, Bao L, Yu P, Qi F, Gong S, Wang J, Zhao B, Liu M, Han Y, Deng W, et al. (2020). SARS-CoV-2 Causes a Systemically Multiple Organs Damages and Dissemination in Hamsters. Front. Microbiol 11, 618891. 10.3389/fmicb.2020.618891.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmicb.2020.618891</ArticleId><ArticleId IdType="pmc">PMC7835519</ArticleId><ArticleId IdType="pubmed">33510731</ArticleId></ArticleIdList></Reference><Reference><Citation>Boudewijns R, Thibaut HJ, Kaptein SJF, Li R, Vergote V, Seldeslachts L, Van Weyenbergh J, De Keyzer C, Bervoets L, Sharma S, et al. (2020). STAT2 signaling restricts viral dissemination but drives severe pneumonia in SARS-CoV-2 infected hamsters. Nat. Commun 11, 5838. 10.1038/s41467-020-19684-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-020-19684-y</ArticleId><ArticleId IdType="pmc">PMC7672082</ArticleId><ArticleId IdType="pubmed">33203860</ArticleId></ArticleIdList></Reference><Reference><Citation>Imai M, Iwatsuki-Horimoto K, Hatta M, Loeber S, Halfmann PJ, Nakajima N, Watanabe T, Ujie M, Takahashi K, Ito M, et al. (2020). Syrian hamsters as a small animal model for SARS-CoV-2 infection and countermeasure development. Proc. Natl. Acad. Sci. U. S. A 117, 16587&#x2013;16595. 10.1073/pnas.2009799117.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.2009799117</ArticleId><ArticleId IdType="pmc">PMC7368255</ArticleId><ArticleId IdType="pubmed">32571934</ArticleId></ArticleIdList></Reference><Reference><Citation>Sia SF, Yan L-M, Chin AWH, Fung K, Choy K-T, Wong AYL, Kaewpreedee P, Perera RAPM, Poon LLM, Nicholls JM, et al. (2020). Pathogenesis and transmission of SARS-CoV-2 in golden hamsters. Nature 583, 834&#x2013;838. 10.1038/s41586-020-2342-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-020-2342-5</ArticleId><ArticleId IdType="pmc">PMC7394720</ArticleId><ArticleId IdType="pubmed">32408338</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang S-J, Wei T-C, Hsu C-H, Ho S-N, Lai C-Y, Huang S-F, Chen Y-Y, Liu S-J, Yu G-Y, and Dou H-Y (2021). Characterization of Virus Replication, Pathogenesis, and Cytokine Responses in Syrian Hamsters Inoculated with SARS-CoV-2. J. Inflamm. Res 14, 3781&#x2013;3795. 10.2147/JIR.S323026.</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/JIR.S323026</ArticleId><ArticleId IdType="pmc">PMC8366787</ArticleId><ArticleId IdType="pubmed">34408462</ArticleId></ArticleIdList></Reference><Reference><Citation>Frere JJ, Serafini RA, Pryce KD, Zazhytska M, Oishi K, Golynker I, Panis M, Zimering J, Horiuchi S, Hoagland DA, et al. (2022). SARS-CoV-2 infection in hamsters and humans results in lasting and unique systemic perturbations after recovery. Sci. Transl. Med 14, eabq3059. 10.1126/scitranslmed.abq3059.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/scitranslmed.abq3059</ArticleId><ArticleId IdType="pmc">PMC9210449</ArticleId><ArticleId IdType="pubmed">35857629</ArticleId></ArticleIdList></Reference><Reference><Citation>Heydemann L, Ciurkiewicz M, Beythien G, Becker K, Schughart K, Stanelle-Bertram S, Schaumburg B, Mounogou-Kouassi N, Beck S, Zickler M, et al. (2023). Hamster model for post-COVID-19 alveolar regeneration offers an opportunity to understand post-acute sequelae of SARS-CoV-2. Nat. Commun 14, 3267. 10.1038/s41467-023-39049-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-023-39049-5</ArticleId><ArticleId IdType="pmc">PMC10241385</ArticleId><ArticleId IdType="pubmed">37277327</ArticleId></ArticleIdList></Reference><Reference><Citation>Rizvi ZA, Dalai R, Sadhu S, Binayke A, Dandotiya J, Kumar Y, Shrivastava T, Gupta SK, Aggarwal S, Tripathy MR, et al. (2022). Golden Syrian hamster as a model to study cardiovascular complications associated with SARS-CoV-2 infection. eLife 11, e73522. 10.7554/eLife.73522.</Citation><ArticleIdList><ArticleId IdType="doi">10.7554/eLife.73522</ArticleId><ArticleId IdType="pmc">PMC8794466</ArticleId><ArticleId IdType="pubmed">35014610</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang AJ, Lee AC-Y, Chu H, Chan JF-W, Fan Z, Li C, Liu F, Chen Y, Yuan S, Poon VK-M, et al. (2021). Severe Acute Respiratory Syndrome Coronavirus 2 Infects and Damages the Mature and Immature Olfactory Sensory Neurons of Hamsters. Clin. Infect. Dis. Off. Publ. Infect. Dis. Soc. Am 73, e503&#x2013;e512. 10.1093/cid/ciaa995.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciaa995</ArticleId><ArticleId IdType="pmc">PMC7454453</ArticleId><ArticleId IdType="pubmed">32667973</ArticleId></ArticleIdList></Reference><Reference><Citation>Bryche B, St Albin A, Murri S, Lac&#xf4;te S, Pulido C, ArGouilh M, Lesellier S, Servat A, Wasniewski M, Picard-Meyer E, et al. (2020). Massive transient damage of the olfactory epithelium associated with infection of sustentacular cells by SARS-CoV-2 in golden Syrian hamsters. Brain. Behav. Immun 89, 579&#x2013;586. 10.1016/j.bbi.2020.06.032.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbi.2020.06.032</ArticleId><ArticleId IdType="pmc">PMC7332942</ArticleId><ArticleId IdType="pubmed">32629042</ArticleId></ArticleIdList></Reference><Reference><Citation>Reyna RA, Kishimoto-Urata M, Urata S, Makishima T, Paessler S, and Maruyama J (2022). Recovery of anosmia in hamsters infected with SARS-CoV-2 is correlated with repair of the olfactory epithelium. Sci. Rep 12, 628. 10.1038/s41598-021-04622-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-021-04622-9</ArticleId><ArticleId IdType="pmc">PMC8755745</ArticleId><ArticleId IdType="pubmed">35022504</ArticleId></ArticleIdList></Reference><Reference><Citation>Kishimoto-Urata M, Urata S, Kagoya R, Imamura F, Nagayama S, Reyna RA, Maruyama J, Yamasoba T, Kondo K, Hasegawa-Ishii S, et al. (2022). Prolonged and extended impacts of SARS-CoV-2 on the olfactory neurocircuit. Sci. Rep 12, 5728. 10.1038/S41598-022-09731-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/S41598-022-09731-7</ArticleId><ArticleId IdType="pmc">PMC8987081</ArticleId><ArticleId IdType="pubmed">35388072</ArticleId></ArticleIdList></Reference><Reference><Citation>Munster VJ, Feldmann F, Williamson BN, van Doremalen N, P&#xe9;rez-P&#xe9;rez L, Schulz J, Meade-White K, Okumura A, Callison J, Brumbaugh B, et al. (2020). Respiratory disease in rhesus macaques inoculated with SARS-CoV-2. Nature 585, 268&#x2013;272. 10.1038/S41586-020-2324-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/S41586-020-2324-7</ArticleId><ArticleId IdType="pmc">PMC7486227</ArticleId><ArticleId IdType="pubmed">32396922</ArticleId></ArticleIdList></Reference><Reference><Citation>Shan C, Yao Y-F, Yang X-L, Zhou Y-W, Gao G, Peng Y, Yang L, Hu X, Xiong J, Jiang R-D, et al. (2020). Infection with novel coronavirus (SARS-CoV-2) causes pneumonia in Rhesus macaques. Cell Res. 30, 670&#x2013;677. 10.1038/s41422-020-0364-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41422-020-0364-z</ArticleId><ArticleId IdType="pmc">PMC7364749</ArticleId><ArticleId IdType="pubmed">32636454</ArticleId></ArticleIdList></Reference><Reference><Citation>Salguero FJ, White AD, Slack GS, Fotheringham SA, Bewley KR, Gooch KE, Longet S, Humphries HE, Watson RJ, Hunter L, et al. (2021). Comparison of rhesus and cynomolgus macaques as an infection model for COVID-19. Nat. Commun 12, 1260. 10.1038/S41467-021-21389-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/S41467-021-21389-9</ArticleId><ArticleId IdType="pmc">PMC7904795</ArticleId><ArticleId IdType="pubmed">33627662</ArticleId></ArticleIdList></Reference><Reference><Citation>Rockx B, Kuiken T, Herfst S, Bestebroer T, Lamers MM, Oude Munnink BB, de Meulder D, van Amerongen G, van den Brand J, Okba NMA, et al. (2020). Comparative pathogenesis of COVID-19, MERS, and SARS in a nonhuman primate model. Science 368, 1012&#x2013;1015. 10.1126/science.abb7314.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abb7314</ArticleId><ArticleId IdType="pmc">PMC7164679</ArticleId><ArticleId IdType="pubmed">32303590</ArticleId></ArticleIdList></Reference><Reference><Citation>Zheng H, Li H, Guo L, Liang Y, Li J, Wang X, Hu Y, Wang L, Liao Y, Yang F, et al. (2020). Virulence and pathogenesis of SARS-CoV-2 infection in rhesus macaques: A nonhuman primate model of COVID-19 progression. PLoS Pathog. 16, e1008949. 10.1371/journal.ppat.1008949.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1008949</ArticleId><ArticleId IdType="pmc">PMC7660522</ArticleId><ArticleId IdType="pubmed">33180882</ArticleId></ArticleIdList></Reference><Reference><Citation>B&#xf6;sz&#xf6;rm&#xe9;nyi KP, Stammes MA, Fagrouch ZC, Kiemenyi-Kayere G, Niphuis H, Mortier D, van Driel N, Nieuwenhuis I, Vervenne RAW, Haaksma T, et al. (2021). The Post-Acute Phase of SARS-CoV-2 Infection in Two Macaque Species Is Associated with Signs of Ongoing Virus Replication and Pathology in Pulmonary and Extrapulmonary Tissues. Viruses 13, 1673. 10.3390/v13081673.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v13081673</ArticleId><ArticleId IdType="pmc">PMC8402919</ArticleId><ArticleId IdType="pubmed">34452537</ArticleId></ArticleIdList></Reference><Reference><Citation>Woolsey C, Borisevich V, Prasad AN, Agans KN, Deer DJ, Dobias NS, Heymann JC, Foster SL, Levine CB, Medina L, et al. (2021). Establishment of an African green monkey model for COVID-19 and protection against re-infection. Nat. Immunol 22, 86&#x2013;98. 10.1038/s41590-020-00835-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41590-020-00835-8</ArticleId><ArticleId IdType="pmc">PMC7790436</ArticleId><ArticleId IdType="pubmed">33235385</ArticleId></ArticleIdList></Reference><Reference><Citation>Cross RW, Agans KN, Prasad AN, Borisevich V, Woolsey C, Deer DJ, Dobias NS, Geisbert JB, Fenton KA, and Geisbert TW (2020). Intranasal exposure of African green monkeys to SARS-CoV-2 results in acute phase pneumonia with shedding and lung injury still present in the early convalescence phase. Virol. J 17, 125. 10.1186/s12985-020-01396-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12985-020-01396-w</ArticleId><ArticleId IdType="pmc">PMC7431901</ArticleId><ArticleId IdType="pubmed">32811514</ArticleId></ArticleIdList></Reference><Reference><Citation>Fahlberg MD, Blair RV, Doyle-Meyers LA, Midkiff CC, Zenere G, Russell-Lodrigue KE, Monjure CJ, Haupt EH, Penney TP, Lehmicke G, et al. (2020). Cellular events of acute, resolving or progressive COVID-19 in SARS-CoV-2 infected non-human primates. Nat. Commun 11, 6078. 10.1038/s41467-020-19967-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-020-19967-4</ArticleId><ArticleId IdType="pmc">PMC7695721</ArticleId><ArticleId IdType="pubmed">33247138</ArticleId></ArticleIdList></Reference><Reference><Citation>Hartman AL, Nambulli S, McMillen CM, White AG, Tilston-Lunel NL, Albe JR, Cottle E, Dunn MD, Frye LJ, Gilliland TH, et al. (2020). SARS-CoV-2 infection of African green monkeys results in mild respiratory disease discernible by PET/CT imaging and shedding of infectious virus from both respiratory and gastrointestinal tracts. PLoS Pathog. 16, e1008903. 10.1371/journal.ppat.1008903.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1008903</ArticleId><ArticleId IdType="pmc">PMC7535860</ArticleId><ArticleId IdType="pubmed">32946524</ArticleId></ArticleIdList></Reference><Reference><Citation>Koo B-S, Oh H, Kim G, Hwang E-H, Jung H, Lee Y, Kang P, Park J-H, Ryu C-M, and Hong JJ (2020). Transient Lymphopenia and Interstitial Pneumonia With Endotheliitis in SARS-CoV-2&#x2013;Infected Macaques. J. Infect. Dis 222, 1596&#x2013;1600. 10.1093/infdis/jiaa486.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/jiaa486</ArticleId><ArticleId IdType="pmc">PMC7454693</ArticleId><ArticleId IdType="pubmed">32745172</ArticleId></ArticleIdList></Reference><Reference><Citation>Blair RV, Vaccari M, Doyle-Meyers LA, Roy CJ, Russell-Lodrigue K, Fahlberg M, Monjure CJ, Beddingfield B, Plante KS, Plante JA, et al. (2021). Acute Respiratory Distress in Aged, SARS-CoV-2-Infected African Green Monkeys but Not Rhesus Macaques. Am. J. Pathol 191, 274&#x2013;282. 10.1016/j.ajpath.2020.10.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajpath.2020.10.016</ArticleId><ArticleId IdType="pmc">PMC7648506</ArticleId><ArticleId IdType="pubmed">33171111</ArticleId></ArticleIdList></Reference><Reference><Citation>Huot N, Planchais C, Rosenbaum P, Contreras V, Jacquelin B, Petitdemange C, Lazzerini M, Beaumont E, Orta-Resendiz A, Rey FA, et al. (2023). SARS-CoV-2 viral persistence in lung alveolar macrophages is controlled by IFN-&#x3b3; and NK cells. Nat. Immunol, 1&#x2013;12. 10.1038/s41590-023-01661-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41590-023-01661-4</ArticleId><ArticleId IdType="pmc">PMC10681903</ArticleId><ArticleId IdType="pubmed">37919524</ArticleId></ArticleIdList></Reference><Reference><Citation>Li H, McLaurin KA, Mactutus CF, Rappaport J, Datta PK, and Booze RM (2023). SARS-CoV-2 RNA persists in the central nervous system of non-human primates despite clinical recovery. Mol. Biomed 4, 39. 10.1186/s43556-023-00153-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s43556-023-00153-z</ArticleId><ArticleId IdType="pmc">PMC10630293</ArticleId><ArticleId IdType="pubmed">37934362</ArticleId></ArticleIdList></Reference><Reference><Citation>Rutkai I, Mayer MG, Hellmers LM, Ning B, Huang Z, Monjure CJ, Coyne C, Silvestri R, Golden N, Hensley K, et al. (2022). Neuropathology and virus in brain of SARS-CoV-2 infected non-human primates. Nat. Commun 13, 1745. 10.1038/s41467-022-29440-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-022-29440-z</ArticleId><ArticleId IdType="pmc">PMC8975902</ArticleId><ArticleId IdType="pubmed">35365631</ArticleId></ArticleIdList></Reference><Reference><Citation>Philippens IHCHM, B&#xf6;sz&#xf6;rm&#xe9;nyi KP, Wubben JAM, Fagrouch ZC, van Driel N, Mayenburg AQ, Lozovagia D, Roos E, Schurink B, Bugiani M, et al. (2022). Brain Inflammation and Intracellular &#x3b1;-Synuclein Aggregates in Macaques after SARS-CoV-2 Infection. Viruses 14, 776. 10.3390/v14040776.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v14040776</ArticleId><ArticleId IdType="pmc">PMC9025893</ArticleId><ArticleId IdType="pubmed">35458506</ArticleId></ArticleIdList></Reference><Reference><Citation>Nieuwland JM, Nutma E, Philippens IHCHM, B&#xf6;sz&#xf6;rm&#xe9;nyi KP, Remarque EJ, Bakker J, Meijer L, Woerdman N, Fagrouch ZC, Verstrepen BE, et al. (2023). Longitudinal positron emission tomography and postmortem analysis reveals widespread neuroinflammation in SARS-CoV-2 infected rhesus macaques. J. Neuroinflammation 20, 179. 10.1186/S12974-023-02857-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/S12974-023-02857-z</ArticleId><ArticleId IdType="pmc">PMC10387202</ArticleId><ArticleId IdType="pubmed">37516868</ArticleId></ArticleIdList></Reference><Reference><Citation>Coleman C, Doyle-Meyers LA, Russell-Lodrigue KE, Golden N, Threeton B, Song K, Pierre G, Baribault C, Bohm RP, Maness NJ, et al. (2021). Similarities and Differences in the Acute-Phase Response to SARS-CoV-2 in Rhesus Macaques and African Green Monkeys. Front. Immunol 12, 754642. 10.3389/fimmu.2021.754642.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.754642</ArticleId><ArticleId IdType="pmc">PMC8527883</ArticleId><ArticleId IdType="pubmed">34691074</ArticleId></ArticleIdList></Reference><Reference><Citation>Yasui F, Matsumoto Y, Yamamoto N, Sanada T, Honda T, Munakata T, Itoh Y, and Kohara M (2022). Infection with the SARS-CoV-2 B. 1.351 variant is lethal in aged BALB/cmice. Sci. Rep 72, 4150. 10.1038/s41598-022-08104-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-022-08104-4</ArticleId><ArticleId IdType="pmc">PMC8907250</ArticleId><ArticleId IdType="pubmed">35264719</ArticleId></ArticleIdList></Reference><Reference><Citation>Halfmann PJ, Kuroda M, Armbrust T, Theiler J, Balaram A, Moreno GK, Accola MA, Iwatsuki-Horimoto K, Valdez R, Stoneman E, et al. Characterization of the SARS-CoV-2 B.1.621 (Mu) variant. Sci. Transl. Med, eabm4908. 10.1126/scitranslmed.abm4908.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/scitranslmed.abm4908</ArticleId><ArticleId IdType="pmc">PMC9392899</ArticleId><ArticleId IdType="pubmed">35579540</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheong J-G, Ravishankar A, Sharma S, Parkhurst CN, Grassmann SA, Wingert CK, Laurent P, Ma S, Paddock L, Miranda IC, et al. (2023). Epigenetic memory of coronavirus infection in innate immune cells and their progenitors. Cell 186, 3882&#x2013;3902.e24. 10.1016/j.cell.2023.07.019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2023.07.019</ArticleId><ArticleId IdType="pmc">PMC10638861</ArticleId><ArticleId IdType="pubmed">37597510</ArticleId></ArticleIdList></Reference><Reference><Citation>Masciarella AD, Di Gregorio DM, Ramamoorthy R, Hussain H, Jayakumar AR, and Paidas MJ (2023). A Mouse Model of MHV-1 Virus Infection for Study of Acute and Long COVID Infection. Curr. Protoc 3, e896. 10.1002/cpz1.896.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/cpz1.896</ArticleId><ArticleId IdType="pmc">PMC10606938</ArticleId><ArticleId IdType="pubmed">37867460</ArticleId></ArticleIdList></Reference><Reference><Citation>Paidas MJ, Cosio DS, Ali S, Kenyon NS, and Jayakumar AR (2022). Long-Term Sequelae of COVID-19 in Experimental Mice. Mol. Neurobiol 59, 5970&#x2013;5986.10.1007/s12035-022-02932-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12035-022-02932-1</ArticleId><ArticleId IdType="pmc">PMC9281331</ArticleId><ArticleId IdType="pubmed">35831558</ArticleId></ArticleIdList></Reference><Reference><Citation>Ramamoorthy R, Hussain H, Ravelo N, Sriramajayam K, Di Gregorio DM, Paulrasu K, Chen P, Young K, Masciarella AD, Jayakumar AR, et al. (2023). Kidney Damage in Long COVID: Studies in Experimental Mice. Biology 12, 1070.10.3390/biology12081070.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biology12081070</ArticleId><ArticleId IdType="pmc">PMC10452084</ArticleId><ArticleId IdType="pubmed">37626956</ArticleId></ArticleIdList></Reference><Reference><Citation>Gressett TE, Leist SR, Ismael S, Talkington G, Dinnon KH, Baric RS, and Bix G (2023). Mouse Adapted SARS-CoV-2 Model Induces &#x201c;Long-COVID&#x201d; Neuropathology in BALB/cMice. Preprint at bioRxiv, 10.1101/2023.03.18.533204 10.1101/2023.03.18.533204.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2023.03.18.533204</ArticleId></ArticleIdList></Reference><Reference><Citation>Dinnon KH, Leist SR, Okuda K, Dang H, Fritch EJ, Gully KL, De la Cruz G, Evangelista MD, Asakura T, Gilmore RC, et al. (2022). SARS-CoV-2 infection produces chronic pulmonary epithelial and immune cell dysfunction with fibrosis in mice. Sci. Transl. Med 14, eabo5070. 10.1126/scitranslmed.abo5070.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/scitranslmed.abo5070</ArticleId><ArticleId IdType="pmc">PMC9273046</ArticleId><ArticleId IdType="pubmed">35857635</ArticleId></ArticleIdList></Reference><Reference><Citation>Lercher A, Cheong J-G, Jiang C, Hoffmann H-H, Ashbrook AW, Yin YS, Quirk C, DeGrace EJ, Chiriboga L, Rosenberg BR, et al. (2023). Antiviral innate immune memory in alveolar macrophages following SARS-CoV-2 infection. Preprint at bioRxiv, 10.1101/2023.11.24.568354 10.1101/2023.11.24.568354.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2023.11.24.568354</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang L, Li YH, Kibler K, Kraberger S, Varsani A, Turk J, Elmadbouly N, Aliskevich E, Spaccarelli L, Estifanos B, et al. (2023). Viral anti-inflammatory serpin reduces immuno-coagulopathic pathology in SARS-CoV-2 mouse models of infection. EMBO Mol. Med 15, e17376. 10.15252/emmm.202317376.</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/emmm.202317376</ArticleId><ArticleId IdType="pmc">PMC10493584</ArticleId><ArticleId IdType="pubmed">37534622</ArticleId></ArticleIdList></Reference><Reference><Citation>Leist SR, Dinnon KH, Sch&#xe4;fer A, Tse LV, Okuda K, Hou YJ, West A, Edwards CE, Sanders W, Fritch EJ, et al. (2020). A Mouse-Adapted SARS-CoV-2 Induces Acute Lung Injury and Mortality in Standard Laboratory Mice. Cell 183, 1070&#x2013;1085.e12. 10.1016/j.cell.2020.09.050.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2020.09.050</ArticleId><ArticleId IdType="pmc">PMC7510428</ArticleId><ArticleId IdType="pubmed">33031744</ArticleId></ArticleIdList></Reference><Reference><Citation>Suryawanshi RK, Chen IP, Ma T, Syed AM, Brazer N, Saldhi P, Simoneau CR, Ciling A, Khalid MM, Sreekumar B, et al. (2022). Limited cross-variant immunity from SARS-CoV-2 Omicron without vaccination. Nature 607, 351&#x2013;355. 10.1038/s41586-022-04865-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-022-04865-0</ArticleId><ArticleId IdType="pmc">PMC9279157</ArticleId><ArticleId IdType="pubmed">35584773</ArticleId></ArticleIdList></Reference><Reference><Citation>Seehusen F, Clark JJ, Sharma P, Bentley EG, Kirby A, Subramaniam K, Wunderlin-Giuliani S, Hughes GL, Patterson EI, Michael BD, et al. (2022). Neuroinvasion and Neurotropism by SARS-CoV-2 Variants in the K18-hACE2 Mouse. Viruses 14, 1020. 10.3390/v14051020.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v14051020</ArticleId><ArticleId IdType="pmc">PMC9146514</ArticleId><ArticleId IdType="pubmed">35632761</ArticleId></ArticleIdList></Reference><Reference><Citation>Ma T, Suryawanshi RK, Miller SR, Ly KK, Thomas R, Elphick N, Yin K, Luo X, Kaliss N, Chen IP, et al. (2023). Post-acute immunological and behavioral sequelae in mice after Omicron infection. BioRxiv Prepr. Serv. Biol, 2023.06.05.543758. 10.1101/2023.06.05.543758.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2023.06.05.543758</ArticleId></ArticleIdList></Reference><Reference><Citation>Israelow B, Song E, Mao T, Lu P, Meir A, Liu F, Alfajaro MM, Wei J, Dong H, Homer RJ, et al. (2020). Mouse model of SARS-CoV-2 reveals inflammatory role of type I interferon signaling. J. Exp. Med 217, e20201241. 10.1084/jem.20201241.</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.20201241</ArticleId><ArticleId IdType="pmc">PMC7401025</ArticleId><ArticleId IdType="pubmed">32750141</ArticleId></ArticleIdList></Reference><Reference><Citation>Cui L, Fang Z, De Souza CM, Lerbs T, Guan Y, Li I, Charu V, Chen S-Y, Weissman I, and Wernig G (2023). Innate immune cell activation causes lung fibrosis in a humanized model of long COVID. Proc. Natl. Acad. Sci 120, e2217199120. 10.1073/pnas.2217199120.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.2217199120</ArticleId><ArticleId IdType="pmc">PMC10013740</ArticleId><ArticleId IdType="pubmed">36848564</ArticleId></ArticleIdList></Reference><Reference><Citation>Sefik E, Israelow B, Mirza H, Zhao J, Qu R, Kaffe E, Song E, Halene S, Meffre E, Kluger Y, et al. (2022). A humanized mouse model of chronic COVID-19. Nat. Biotechnol 40, 906&#x2013;920. 10.1038/s41587-021-01155-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41587-021-01155-4</ArticleId><ArticleId IdType="pmc">PMC9203605</ArticleId><ArticleId IdType="pubmed">34921308</ArticleId></ArticleIdList></Reference><Reference><Citation>Cao X, Nguyen V, Tsai J, Gao C, Tian Y, Zhang Y, Carver W, Kiaris H, Cui T, and Tan W (2023). The SARS-CoV-2 spike protein induces long-term transcriptional perturbations of mitochondrial metabolic genes, causes cardiac fibrosis, and reduces myocardial contractile in obese mice. Mol. Metab 74, 101756. 10.1016/j.molmet.2023.101756.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molmet.2023.101756</ArticleId><ArticleId IdType="pmc">PMC10281040</ArticleId><ArticleId IdType="pubmed">37348737</ArticleId></ArticleIdList></Reference><Reference><Citation>Fontes-Dantas FL, Fernandes GG, Gutman EG, De Lima EV, Antonio LS, Hammerle MB, Mota-Araujo HP, Colodeti LC, Ara&#xfa;jo SMB, Froz GM, et al. (2023). SARS-CoV-2 Spike protein induces TLR4-mediated long-term cognitive dysfunction recapitulating post-COVID-19 syndrome in mice. Cell Rep. 42, 112189.10.1016/j.celrep.2023.112189.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2023.112189</ArticleId><ArticleId IdType="pmc">PMC9935273</ArticleId><ArticleId IdType="pubmed">36857178</ArticleId></ArticleIdList></Reference><Reference><Citation>Conferences | Keystone Symposia.   https://www.keystonesymposia.org/conferences/conference-listing/meeting?eventid=7027.</Citation></Reference><Reference><Citation>Frequently Asked Questions | RECOVER COVID Initiative; 
https://recovercovid.org/faqs.</Citation></Reference><Reference><Citation>About the Initiative | RECOVER COVID Initiative; 
https://recovercovid.org/.</Citation></Reference><Reference><Citation>RECOVER Publications | RECOVER COVID Initiative;  (2023). https://recovercovid.org/publications.</Citation></Reference><Reference><Citation>RECOVER Clinical Trials | Home; 
https://trials.recovercovid.org/.</Citation></Reference><Reference><Citation>RECOVER-NEURO enrolls first participant in trial | RECOVER COVID Initiative; 
https://recovercovid.org/updates/recover-neuro-enrolls-first-participant.</Citation></Reference><Reference><Citation>RECOVER-VITAL enrolls first participant in trial | RECOVER COVID Initiative; 
https://recovercovid.org/updates/recover-vital-enrolls-first-participant.</Citation></Reference><Reference><Citation>RECOVER Clinical Trials | AUTONOMIC; 
https://trials.recovercovid.org/autonomic.</Citation></Reference><Reference><Citation>Brodin P (2023). An Interventional, Double-Blinded, 2-Arm Study to Investigate the Efficacy of Orally Administered Nirmatrelvir/Ritonavir Compared With Placebo/Ritonavir in Non-hospitalized Adult Participants Suffering From Post-COVID (clinicaltrials.gov).</Citation></Reference><Reference><Citation>Haukeland University Hospital (2023). PAxlovid loNg cOvid-19 pRevention triAl With recruitMent In the Community in Norway (clinicaltrials.gov).</Citation></Reference><Reference><Citation>Krumholz HM (2023). An Interventional Decentralized Phase 2, Randomized, Double-Blind, 2-Arm Study to Investigate the Efficacy and Safety of Orally Administered Nirmatrelvir/Ritonavir Compared Wth Placebo/Ritonavir in Participants With Long COVID (clinicaltrials.gov).</Citation></Reference><Reference><Citation>Stanford University (2023). Selective Trial Of Paxlovid for PASC (STOP-PASC): Randomized Double-Blind Placebo-Controlled Pilot Trial of Paxlovid for the Treatment of PASC (clinicaltrials.gov).</Citation></Reference><Reference><Citation>Backman I
Participant-centric Trial Will Test if Antiviral Paxlovid Can Help With Long COVID. https://medicine.yale.edu/news-article/participant-centric-trial-will-test-if-anti-viral-paxlovid-can-help-with-long-covid/.</Citation></Reference><Reference><Citation>Mccamic E (2023). Grand Rounds October 27, 2023: Digital, Decentralized and Democratized: Lessons From The Yale PaxLC Trial (Harlan M. Krumholz, MD, SM). Rethink. Clin. Trials
https://rethinkingclinicaltrials.org/news/grand-rounds-october-27-2023-digital-decentralized-and-democratized-lessons-from-the-yale-paxlc-trial-harlan-m-krumholz-md-sm/.</Citation></Reference><Reference><Citation>Taghrir MH, Akbarialiabad H, Abdollahi A, Ghahramani N, Bastani B, Paydar S, Razani B, Mwangi J, Asadi-Pooya AA, Roozbeh J, et al. (2023). Inequity and disparities mar existing global research evidence on Long COVID. Glob. Health Promot 30, 63&#x2013;67. 10.1177/17579759221113276.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/17579759221113276</ArticleId><ArticleId IdType="pmc">PMC10076956</ArticleId><ArticleId IdType="pubmed">35962520</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>